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ABSTRACT OF THIS THESIS 
 
The studies described in this thesis were the first to investigate in-depth body composition, 
exercise performance and neuromuscular characteristics of elite Paralympic athletes with 
cerebral palsy (CP). 
 
In the first study, in-depth whole body and site specific body composition was investigated in 
six athletes with CP using dual-energy x-ray absorptiometry.  There were no differences 
between non-affected and affected sides with respect to bone mineral density and fat mass.  
Fat free soft tissue mass was lower on the affected side in both upper and lower limbs of the 
athletes.  The novel findings of this study provided the first insight into anthropometric and 
bone physiology of elite Paralympic athletes with CP, and the possible residual effect of CP 
in these individuals. 
 
In the second study, five athletes with CP and 16 able-bodied (AB) age and performance 
matched controls performed a 30 second Wingate sprint cycle test.  Power output was 
significantly higher in the AB group, although fatigue indices were statistically similar 
between groups.  Muscle activity changed similarly in all muscle groups tested, in both 
affected and non-affected sides, in both CP and AB groups.  However, certain 
neuromuscular irregularities were identified in the CP group.  The similarity in fatigue profile 
was a novel finding.  It was proposed that this similarity in fatigue was the result of long term 
high level athletic training required for Paralympic competition. 
 
Study three tested the similarity in fatigue between CP and AB athletes (that was described 
in the second study), using an externally paced fatiguing running trial.  Six athletes with CP 
and 12 AB athletes performed one 40 m sprint test and vertical jump tests off both legs, the 
affected leg individually and the non-affected leg individually, before and after an adapted 
multistage shuttle run test to exhaustion.  The 40 m sprint test, vertical jump off both legs 
and vertical jump off the affected leg were significantly compromised in the CP group, while 
vertical jump off the non-affected leg was similar between groups.  Both groups fatigued 
similarly with regard to performance and muscle activity.  The third study’s findings generally 
supported those of the second study.  However, it was shown that although athletes with CP 
may represent a group of individuals who have achieved maximal physiological adaptation 
toward AB levels, the activity generated by both legs was performed towards the capacity of 
the affected leg. 
 
Study four attempted to elucidate explanations for the novel findings in studies 2 and 3 
through investigation of pacing strategies employed by these athletes.  Six athletes with CP 
and 13 AB athletes performed two trials of eight sets of ten shuttles (totalling 1600 m).  One 
trial was distance deceived and the other was non distance deceived.  The CP group ran 
slower than the AB group in both trials, and differences in pacing were observed in the 
deceived trial in the CP group.  This novel study provided evidence for a possible pacing 
strategy underlying the exercise performance and fatigue profiles observed in the athletes 
with CP documented in the previous studies. 
 
The work described in this thesis lends novel insights and understanding to the physiology 
and physiological adaptations of highly functioning ambulant athletes with CP.  The findings 
might have important implications with respect to the understanding of rehabilitation, 
coaching and clinical management of individuals with CP. 
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SUMMARY OF STUDIES INCLUDED IN THIS THESIS 
 
Study 1 
The first study in this thesis investigated in-depth whole body and site specific body 
composition in six elite Paralympic athletes with cerebral palsy (CP) using dual-energy x-ray 
absorptiometry.  Bone mineral density (BMD, g/cm2), BMD Z scores (standard deviations), 
fat mass (FM, kg) and fat free soft tissue mass (FFSTM, kg) were measured in specific sites 
on both affected and non-affected sides.  There were no differences between affected and 
non-affected sides with respect to BMD, BMD Z scores and FM.  FFSTM was significantly 
lower on the affected side in both upper and lower limbs (15% lower, P < 0.05).  The 
similarity in BMD between sides as well as FM symmetry provided the first insight into 
physiological adaptation toward typically-developed individuals in elite athletes with CP, 
possibly as the result of high level, long term athletic training.  Lower whole body BMD and 
asymmetry in FFSTM between the affected and non-affected sides indicated that there may 
be a residual effect of CP on the body that limits this adaptation at a certain point. 
 
Study 2 
The aim of the second study was to investigate sprint cycling performance and 
neuromuscular characteristics of elite Paralympic athletes with CP during a fatiguing 
maximal cycling trial, compared to able-bodied (AB) athletes.  Five elite athletes with CP and 
16 AB age and performance matched controls performed a 30 second Wingate sprint cycle 
test.  Power output (W/kg) and fatigue index (%) were calculated.  Electromyography (EMG) 
was measured in five bilateral muscles and expressed in mean amplitude (% max) and 
median frequency (Hz).  Power output was significantly higher in the AB group (10.4 ± 0.5 
W/kg for the AB group) vs. 9.8 ± 0.5 W/kg for the CP group, P<0.05).  Fatigue index was 
statistically similar between AB (27 ± 0.1%) and CP (25 ± 0.1%).  EMG mean amplitude and 
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frequency changed similarly in all muscle groups tested, in both affected and non-affected 
sides, in CP and AB groups (P < 0.05).  However, neuromuscular irregularities were 
identified in the CP group.  The similarity in fatigue between the CP and AB groups indicated 
that elite athletes with CP may have a different exercise response to others with CP.  As 
proposed in Study 1, it was proposed that these findings may be the result of high level 
training over many years. 
 
Study 3 
Study 3 of the present thesis investigated performance, neuromuscular characteristics and 
fatigue in elite Paralympic athletes with CP during a maximal explosive performance trial, 
compared to well trained, sprint specific AB athletes.  Six Paralympic athletes with 
hemiplegic CP and 12 AB athletes performed one 40m sprint test (40m ST, s) and vertical 
jump tests off both legs (VJ-B, cm), affected leg individually (VJ-A, cm) and non-affected leg 
individually (VJ-NA, cm) before and after an adapted Multistage Shuttle Run test to 
exhaustion.  Electromyography (EMG) of five bilateral muscles was measured for mean 
amplitude (% max).  Significantly compromised performance was observed in the CP group 
during the 40m ST (6 – 9%), VJ-B (18%) and VJ-A (33 – 36%), while VJ-NA was similar 
between groups (P<0.05).  Both groups fatigued similarly in performance as well as EMG 
activity.  Affected side EMG was higher than non-affected EMG in VJ-B and VJ-A in both 
groups.  The similarity in fatigue between CP and AB groups confirmed that Paralympic 
athletes with CP may have overcome the deficits associated with CP, which has been 
documented in sedentary children.  The identified asymmetry may assist with a deeper 
understanding of performance impairment in individuals with CP, as it was shown that 
activity generated by both legs was performed towards the capacity of the affected leg. 
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Study 4 
The fourth study investigated performance and physiological characteristics in order to 
understand pacing strategies adopted by elite Paralympic athletes with CP.  Six Paralympic 
athletes with CP and 13 AB athletes performed two trials of eight sets of 10 shuttles (total 
1600 m).  One trial was distance-deceived (DEC, 1000 m + 600 m) and one trial was non-
deceived (N-DEC, 1600 m), and were performed in a random order.  Time (s), heart rate 
(HR, bpm), ratings of perceived exertion (RPE, units) and electromyography (EMG) of five 
bilateral muscles were reported for each set of both trials.  The CP group ran 10% slower 
than the AB group, and pacing differences were seen in the CP DEC trial, presenting as a 
flattened pacing profile over the trial (P < 0.05).  HR was higher and RPE was lower in the 
CP group in both trials (P < 0.05).  EMG showed small differences between groups, sides 
and trials.  This study provided the first evidence for a possible pacing strategy underlying 
exercise performance and fatigue in CP.  The results of this study show that the athletes with 
CP underperformed the trials compared to the AB group, and that the CP group utilised a 
conservative pacing strategy compared to the AB group.  It was proposed that even at high 
levels of performance as well as significant adaptation of elite athletes’ physiology toward 
able-bodied levels, the residual effects of CP may negatively affect performance through the 
selection of conservative pacing strategies during exercise. 
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CHAPTER 1 
 
CRITICAL REVIEW OF THE LITERATURE 
CHAPTER 1 - The effects of exercise training on performance and functional capacity 
in individuals with cerebral palsy 
The effects of exercise training on performance and 
functional capacity in individuals with cerebral palsy 
 
 
 
 
Certain components of the present chapter has been accepted for publication as a critical 
review article in the South African Journal for Research in Sport, Physical Education and 
Recreation (2015) 
  
Chapter 1 
 
 
Department of Human Biology, University of Cape Town 2 
INTRODUCTION 
 
Cerebral palsy: origins and definitions 
Cerebral palsy (CP) was first termed Little’s Disease after Dr William John Little (1810 - 
1894), who was the first to study infantile malformation, and the first to characterise 
hypertonic diplegic CP, attributing the condition to trauma at birth.  Sir William Osler (1849 - 
1928) later introduced the term “cerebral palsy” during his extensive clinical research on 
children with CP.  Sigmund Freud (1865-1939), although not recognised for many years, 
contributed significantly to the area of CP research by identifying pre-natal causes of the 
condition, as well as grouping the different forms of CP under the umbrella term “infantile 
cerebral palsies” 1, 2. 
 
Cerebral Palsy, defined by Bax in 1964 as “a disorder of posture and movement due to a 
defect or lesion of the immature brain” 3 has an estimated incidence of 2.5 per every 1000 
live births 4.  This definition has since been expanded to include a group of movement 
disorders caused by damage to the immature brain before, during, or directly after birth.  The 
damage occurs in one or more of three main areas in the brain controlling movement, 
namely the motor cortex, cerebellum and basal ganglia 5.  Hypertonic CP is the most 
common form of CP, with athetoid, ataxic and mixed CP being less common 6.  Limb 
distribution of the impairment is present in three main categories, namely hemiplegic, 
diplegic and quadriplegic impairment profiles, where hemiplegic profiles refer to one half (left 
or right) of the body being affected, diplegic profiles refer to two limbs being affected 
together (usually both lower limbs) and quadriplegic profiles refer to all four limbs being 
affected 7. 
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Cerebral palsy and athletic participation 
Participation in competitive sport by individuals with disabilities is a relatively new 
phenomenon, with the first organised sports competition for individuals with disabilities held 
in 1948 for World War II veterans with spinal cord injuries 8.  Between 1948 and 1960, the 
International Stoke Mandeville Games grew in size and eligible impairment types, until the 
first Paralympic Games were held in Rome in 1960.  The Paralympic movement has grown 
over the years, with 4176 athletes from 164 countries competing in the 2012 London 
Paralympic Games, an increase from the 2008 Beijing Paralympic Games which hosted 
3951 athletes from 146 countries.  One of the most populated categories for athletes with 
physical disabilities at the Games is that of CP.  Athletes with CP compete in many sports, 
but predominantly track and field, football, swimming and boccia 9. 
 
Functional classification of cerebral palsy 
For clinical purposes within research, the functional abilities of individuals with CP have been 
classified into five discernible groups within the Gross Motor Function Classification System 
(GMFCS) 10.  The system is scored from minimally affected (level I, unaided ambulation) to 
severely affected (level V, permanent wheelchair use) individuals with CP.  In Paralympic 
classification, athletes with CP are similarly characterised according to functional ability or 
impairment.  For example, eight categorical classes of functional ability have been outlined 
for track and field (T/F) events.  These classes range from T/F 31 - 38, where T/F 31 - 34 
denote more severely affected athletes using wheelchairs, while T/F 35 - 38 comprise 
ambulatory athletes 11-13, 197. 
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Research in cerebral palsy 
With the growth of both clinical and sporting populations with CP over the last century, 
research in CP has been carried out, predominantly addressing the need for improved 
quality of life in individuals with the condition.  Many interventions have aimed to address 
quality of life, exercise therapy being an example.  The use of exercise in the treatment and 
management of individuals with CP has yielded positive results from both traditional and 
alternative methods. 
 
The majority of these studies, however, have focused on quality of life within severely 
affected paediatric patients, and not exercise performance capacity in athletic adults, due in 
part to the relative urgency for research within highly affected populations.  Although 
exercise performance measures are often reported in these studies, no studies to date have 
definitively described exercise and performance capacities of children and adults with CP 
from a sports performance perspective.  Moreover, there is neither consistent nor 
longitudinal evidence for the use of exercise training in improving sport performance in this 
patient population. 
 
To provide consistency on this clinical condition, the present review summarises the current 
literature on the exercise and performance capacities of individuals with CP, describing: 1) 
the effect of CP on specific aspects of exercise performance, 2) the response to exercise 
training in individuals with CP and the results of interventions aimed at improving these 
aspects, and 3) how the physiology underlying the functional or physical deficits present in 
CP can be better understood. 
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For the purpose of this review and subsequent studies described in this thesis, only previous 
studies using individuals in the GMFCS levels I and II were reviewed.  This ensured an 
appropriate comparison of functional performance between individuals with truly ambulant 
CP and typically developed able-bodied (AB) individuals, as GMFCS classifications beyond 
level II infer the use of assistive devices or wheelchairs, which would not enable close 
functional matching.  Also, due to the lack of literature in athletic adult samples, studies 
using paediatric samples have been reviewed.  All literature identified in adults or athletes in 
GMFCS levels I and II were included.  For a complete summary of the intervention studies 
included in this review, refer to Table 1. 
 
METHODS 
 
A literature search was conducted using PubMed, Medline, Embase, Scopus, Web of 
Science, Science Direct and Google Scholar databases from the earliest possible date to 
June 2015.  The medical subject heading (MeSH) terms included cerebral palsy, brain injury, 
spasticity and related terms.  The search terms, matched with the MeSH included 
classification, adult, athlete, exercise training, strength, aerobic, anaerobic, agility, speed, 
flexibility, electromyography, muscle, physical inactivity and related terms.  Abstracts were 
screened, and individual articles were selected based on quality and focus of the studies.  
Furthermore, the reference lists of articles were also searched for further studies.  This 
review primarily investigated individuals with CP, and excluded individuals with traumatic 
brain injury or other neurological disorders causing movement abnormalities.  Only studies 
published in the English language were included.   
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RESULTS AND DISCUSSION 
 
Elite athletic performance is the result of a complex interaction between numerous biomotor 
abilities that confer a physical performance advantage to an individual.  These same 
biomotor abilities are of interest to those who use exercise training to improve functional 
quality of life, and include attributes of strength, aerobic capacity, agility, anaerobic capacity 
and flexibility.  As mentioned previously, little research has investigated performance 
variables in a specifically trained athletic population with CP.  Research has primarily been 
conducted in sedentary children and adults with CP, with the goal of improving quality of life 
via exercise training. 
 
These variables are described below with reference to, firstly, how CP affects the variable, 
and secondly, the effect of specific exercise training interventions on the variable. 
 
Strength 
Strength is the ability of a musculotendinous unit to produce force, both statically and 
dynamically, through different types of muscle contractions 14.  There is a longstanding 
recognition of muscular weakness, or the inability to exert the required force, as an adverse 
component of CP that affects quality of life in individuals affected by the condition 15.  Indeed, 
muscular weakness, which was previously thought not to have an effect on functional 
capacity in CP, is now considered by some to be more harmful to functional ability than 
spasticity 16. 
 
Weakness in individuals with CP has been widely demonstrated, with strength deficits 
ranging from 30 - 73% in children 17-19, and 12 - 52% in adults 20-22.  Only one of these 
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studies (De Groot et al, 2012) used an athletic adult sample, of cycling and soccer athletes.  
They reported an isometric knee extension strength deficit ranging between 31% and 47% in 
elite soccer players and cyclists with CP, compared to AB soccer players and cyclists 22. 
 
Because the strength deficits observed in this population are so large, and have negative 
consequences for normal function, numerous studies have examined how exercise training 
interventions might improve strength and functional performance.  These studies have 
mainly focused on children, specifically for functional gains, but they offer insight into the 
potential improvement capacity that may exist for individuals with CP. 
 
The most compelling studies that support the benefits of muscle strength training in 
individuals with CP have found improvements of between 13% 19 and 69% 23 from six weeks 
of traditional strength training in hemiplegic and diplegic children in GMFCS levels I and II.  
This large range is the likely result of variations in methodology, differences between the 
size of muscle groups trained (smaller upper muscle group and improvement vs. larger lower 
limb muscle group and improvement), as well as normal inter-individual variations in 
response to training.  Studies conducted on adults show similar results in strength gains, but 
with longer intervention periods (10 – 12 weeks) 24-26. 
 
Of particular interest is the effect of strength training on the asymmetry between the affected 
(A) and non-affected (NA) sides after training.  The marked asymmetry between A and NA 
sides observed in individuals with CP has been found to be reduced, though not eliminated, 
by strength gains in hemiplegic profiled individuals, suggesting a larger potential for strength 
gains on the A side.  In a study conducted by Damiano (1998), a 24% asymmetry was 
measured after the six week strength training intervention, and while this was a reduction 
Chapter 1 
 
 
Department of Human Biology, University of Cape Town 8 
from a pre-training asymmetry of 42%, the authors did not speculate whether a longer 
training intervention would further minimise this difference 23.  Their finding does however 
invite this possibility. 
 
As expected, detraining was observed to produce the opposite finding, with complete 
detraining of an adult with CP observed within four weeks of completing a 12 week cycling 
intervention 24.  This individual had experienced an 19% and 22% improvement in 
quadriceps and hamstring strength, respectively, during the 12 week training period 24, 
however the individual returned to baseline capacity four weeks after complete cessation of 
exercise.  It must be acknowledged that the cessation of functional electrical muscle 
stimulation may have influenced the rate of detraining in this individual. 
 
In fact, the detraining-induced loss of strength observed in the above mentioned adult 
individual with CP was greater than that typically observed in well trained and sedentary AB 
adults 27, 28.  This finding suggests that there may be an inability to maintain exercise-induced 
physiological adaptation in individuals with CP, resulting in heightened detraining effects.  No 
research to date has evaluated the adaptation to long term, high level training in individuals 
with CP, nor evaluated individuals who have been involved in high volume exercise training 
for many years, which would allow further understanding of the true effect CP has on the 
body, without the confounding factors of sedentary participants and short duration 
intervention durations. 
 
Aerobic capacity 
The aerobic capacity of children with CP has long been recognised as limited compared to 
that of typically developing children 29.  Reductions in VO2peak ranging from 15 - 42% 
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compared to healthy controls indicate a compromised aerobic capacity in paediatric studies 
29-32.  These findings have been supported by 23 - 45% and 21 - 61% impairments in 
VO2peak in adult men and women, respectively 33, 34. 
 
When comparing AB controls to aerobically trained athletic adults with CP, VO2peak has 
was found to be 0.3% and 21% lower VO2peak for athletes in GMFCS levels I and II, 
respectively.  This is significantly closer to age matched controls compared to other studies 
conducted on sedentary individuals with CP 22, and suggests a potential benefit of exercise 
training. 
 
In terms of performance, compromised aerobic capacity may affect game play in football, 
with elite football players with CP covering 43 - 50% less distance than position matched AB 
controls.  This performance deficit is similar to that seen in other research which uses 
sedentary individuals with CP, although this group did present with a similar running 
economy to the AB control group 35. 
 
Aerobic exercise interventions have been implemented in children as young as two years old 
36.  Although existing intervention studies differ in terms of samples studied, testing methods, 
intervention structure and outcome measures, the general finding is that exercise training 
improves aerobic capacity significantly 37. 
 
Self-selected walking speed, often used as an outcome measure for aerobic capacity in 
young children with CP, increased after training interventions, along with energy efficiency 38-
43.  A more rigorous testing method using the lactate threshold to determine exercise 
intensity has reported a 20% increase in aerobic capacity in children and a 12% increase in 
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aerobic capacity in adults, using a similar protocol 44, 45.  Of interest in these studies was that 
arm ergometry power output was unchanged as a result of the exercise intervention, 
whereas leg ergometry power output improved significantly, indicating larger aerobic 
capacity when training larger muscle groups, as proposed previously 44. 
 
Larger aerobic capacity effects may also be possible with longer training interventions, since 
documented improvements were only seen in week eight (final week) of the intervention.  
This, coupled with the improvements in the paediatric study being almost twice that of the 
adult study, supports the notion that adaptation at a young age might be easier to achieve, 
and therefore higher volumes and intensities of training before adulthood should be 
encouraged. 
 
Anaerobic capacity and Agility 
The ability to perform high-intensity activities over a short duration is a function of both 
anaerobic capacity for the provision of rapidly-available energy, and agility, a function of 
balance, coordination and movement ability.  Both are compromised in individuals with CP 
46-50.   
 
Anaerobic performance of children with CP, assessed using the 30 second Wingate sprint 
cycle test, has been found to be two to four standard deviations lower than in typically 
developing children.  Other studies report a 27 - 46% deficit in peak power output in children 
with CP using an adapted 20 second Wingate sprint cycle test 47-50. 
 
Comparisons of agility between CP and control groups are scarce.  From the available 
literature, it was found that the average time to complete a repeat sprint agility task was 39% 
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longer in children with CP.  Indeed, some participants with CP took over 60 seconds to 
complete a task that took only 19.5 seconds for the AB participants to complete 48. 
 
There is also limited research on the potential to increase anaerobic capacity and agility with 
training in individuals with CP.  In the only study available, Verschuren et al. (2007) found a 
25% and 15% increase in anaerobic capacity and agility, respectively, following an eight 
month intervention targeting these variables 51.  This intervention is one of the longest 
duration interventions in individuals with CP, and also included a four month follow up after 
completion of the study.  This follow-up, during which time no supervised training or 
encouragement to train was provided, revealed a 9% and 4% reduction in anaerobic 
capacity and agility, respectively, from peak values achieved at the end of the 8-month 
programme. 
 
These declines in performance resulted in overall anaerobic capacity and agility that was 
comparable to performances observed at the four-month mark of the training intervention 
and are similar to detraining induced declines in performance observed in AB individuals 27, 
28.  These declines do not, however, resemble the findings of the strength study conducted 
by Johnson and Wainwright (2011) on an adult with CP, where a larger detraining effect was 
seen over a shorter period following the completion of the training programme (see Strength 
section of this review).  This difference in rate of detraining may be explained by individual 
variation (the strength study was a case study of one individual), a shorter intervention in the 
strength study, or a consequence of paediatric individuals being used in the anaerobic and 
agility study.  This may provide further evidence that the cerebral palsied body may be 
unable to maintain adaptation to exercise as an adult due to a lack of childhood exercise 
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induced adaptation.  This would further support early participation in traditional exercise 
programs by children with CP. 
 
Flexibility 
Flexibility is the ability of a muscle to elongate in response to a stretching force, and has 
functional limits for each particular joint 14.  Flexibility in individuals with CP is purportedly 
impaired due to spasticity and contracture, although it has also been attributed to a reduction 
of in-series sarcomeres, muscle atrophy and muscle co-activation 52-58.  A possible benefit of 
impaired flexibility may be increased stability of the involved joint, but a lack of flexibility may 
also decrease performance due to improper biomechanics during movement 59. 
 
Although lack of flexibility and the presence of contractures have been well documented in 
individuals with CP, it has not yet been concluded whether training interventions can 
successfully improve flexibility in this population.  Some interventions have found improved 
dynamic flexibility, muscle tone and reduced spasticity with the use of stretching 
interventions 60, 61, while other studies found no change in flexibility, despite positive changes 
in other parameters like spasticity and functional ability at the conclusion of flexibility 
interventions 62-64.   
 
The differences in these studies may once again be explained by the age of the participants 
included in the studies.  The only study that reported entirely positive results was conducted 
by McPherson et al. (1984) in children with CP 60, while the other studies that reported 
variable or inconclusive results were conducted on adolescents or adults with CP.  Once 
again, this suggests that interventions may be more successful and have possibly longer 
term effects if started at a young age 63, 64. 
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Table 1 summarises exercise interventions included in the present review of the literature. 
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Table 1: Summary of intervention studies included in review 
Study Participants Intervention Outcomes Results 
Type Duration Frequency 
Strength 
Ahlborg et al 
2006 26 
Training group with 
CP: N=7 (21-41 years) 
Control group with CP: 
N=7 (21-41 years) 
Training group: 
Whole body 
vibration 
therapy 
Control group: 
Strength 
training 
  Spasticity Training group: Significantly 
decreased in knee 
extensors 
Isokinetic strength Training group: Significant 
improvement at 30o/s 
Control group: Significant 
improvement at 30o/s and 
90os 
6 minute walk test Training group: NS 
Control group: NS 
Timed up and go test Training group: NS 
Control group: NS 
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Gross motor function test Training group: Improved 
significantly 
Andersson et al 
2003 25 
Training group with 
CP: N=10 (23-44 
years) 
Control group with CP: 
N=7 (25-47 years) 
Strength 
training 
10 weeks 2 days/week Spasticity NS 
Range of movement NS 
Isometric strength Training group: Significant 
improvement (hip extensors, 
hip flexors) 
Control group: NS 
Concentric strength Training group: significant 
improvement at 30o/s and 
90os in knee extensors 
Control group: NS 
Eccentric strength NS 
Gross motor function 
measure  
Training group: Significant 
difference 
Control group: NS 
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6 minute walk test Training group: Significant 
improvement (walking 
distance, walking velocity) 
Control group: NS 
Timed up and go Training group: Significant 
difference 
Control group: NS 
Damiano & Abel 
1998 23 
CP: N=11 (6-12 years) 
Diplegic group: N=6 
Hemiplegic group: N=5 
Strength 
training 
6 weeks 3 days/week Isometric strength 
 
 
 
 
 
Diplegic group: ↑ 69% 
Hemiplegic group: ↑ 20.3% 
in affected leg 
Unaffected leg: NS 
24% asymmetry across 
sides maintained 
3D gait analysis Asymmetry improved 
Gross motor function 
measure 
Improved 
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Healy et al 
1958  
CP: N=5 (8-16 years) Concentric and 
isometric 
strength 
training 
8 weeks 3 days/week Concentric strength 
 
Significant improvement 
Isometric strength 
 
Significant improvement 
Knee ROM NS 
Johnston et al 
2011 24 
CP: N=1 (49 years) Cycling with 
superimposed 
electrical 
stimulation 
12 weeks 3 days/week Spasticity NS 
6 minute walk test NS 
Timed up and go test Significantly improved by 
24.4% 
Concentric strength Hip flexor ↑ 22.2% 
Hip extensor ↑ 18.5% 
Gait parameters NS 
Medical outcomes study 36-
item health survey 
Significantly improved 
International classification of 
functioning, disability and 
Significantly improved 
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health 
MacPhail & 
Kramer 
1995 65 
CP: N=17 (12-20 
years) 
Eccentric, 
isometric, 
concentric 
strength 
training 
8 weeks 3 days/week Peak torque 
Peak work 
Strength ↑ 21-25% 
 
Spasticity NS 
Efficiency NS 
Reid et al 
2010 19 
CP: N=14 (9-15 years) 
Con: N=14 (9-15 
years) 
Progressive 
eccentric 
strength 
program 
6 weeks 3 days/week Peak torque to body mass 
(T/BM) 
Work to body mass (W/BM) 
Concentric task: ↑ 13%  
Eccentric task: ↑ 25% 
Angle at peak torque NS 
Curve width NS 
EMG activation ↓ to normal amplitude 
Toner et al 
1998 66 
CP: N=6 (4-7 years) Strength 
training with 
use of 
biofeedback 
6 weeks 7 days/week Strength NS 
Toe tapping ability Improved 
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Aerobic capacity 
Chan et al 
2004 38 
CP: N=12 (4-11 years) Treadmill 
training and 
electrical 
stimulation 
4 weeks 3 days/week 3D gait analysis NS 
Ankle moment quotient 
Ankle power quotient 
NS 
Gross motor function 
measure 
Significant improvement 
Chrysagis et al 
2012 67 
Training group with CP: 
N=11 
Control group with CP: 
N=11 
Training group: 
Treadmill 
training without 
body weight 
support 
Control group: 
Traditional 
physiotherapy 
12 weeks 3 days/week Spasticity NS 
Self-selected walking speed Training group: Significant 
improvement 
Control group: NS 
Gross motor function 
measure 
Training group: Significantly 
improved 
Control group: NS 
Mattern-Baxter 
et al 
CP: N=6 (2.5-3.9 years) Treadmill 
training 
4 weeks 3 days/week Gross motor function 
measure 
Significant improvement 
Chapter 1 
 
 
Department of Human Biology, University of Cape Town 20 
2009 36 Paediatric evaluation of 
disability inventory 
Significant improvement 
10 m walk test 
6 minute walk test 
Over-ground walking speed 
and distance covered ↑ 
Phillips et al 
2007 42 
CP: N= (6-14 years) Body weight 
supported 
treadmill 
training 
2 weeks 2 times/day 
6 days/week 
fMRI activation fMRI activation increased 
10 m walk test 
6 minute walk test 
Over-ground walking speed 
and distance covered ↑ 
Provost et al 
2007 43 
CP: N= (6-14 years) Body weight 
supported 
treadmill 
training 
2 weeks 2 times/day 
6 days/week 
Energy expenditure Significant improvement in 
energy expenditure 
10 m walk test 
6 minute walk test 
Over-ground walking speed 
and distance covered ↑ 
Single leg balance test NS 
Gross motor function 
measure 
Significant difference 
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Shinohara et 
al 
2002 44 
CP: N=11 
Leg group: N=6 (13.3-
15.8 years) 
Arm group: N=5 (11.8-
16.3) 
Anaerobic 
threshold 
training 
Leg group: 
cycle 
ergometer 
training 
Arm group: arm 
ergometer 
training  
20 weeks 2 days/week VO2 at the anaerobic 
threshold 
Leg group: VO2 ↑ 20% 
Arm group: NS 
Self reported endurance 
capacity 
Children reported a 
perception of increased 
endurance capacity in only 
the leg group 
Anaerobic capacity and Agility 
Verschuren et 
al 
2007 51 
CP: N=86 (7-18 years) 
 
Aerobic and 
anaerobic 
circuit training 
8 months 
 
2 days/week 
 
Muscle power sprint test Anaerobic capacity ↑ 25% 
 
10 x 5 m sprint test Agility ↑ 15% 
Flexibility 
Darrah et al CP: N=23 (11-20 years) Active 10 weeks 3 days/week Spasticity of triceps surae NS 
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1999 63 
 
stretching for 
lower 
extremities 
Sit and reach (hamstring 
flexibility) 
NS 
Adductor flexibility NS 
Dickin et al 
2013 61 
CP: N=8 (20-51 years) Individualised 
whole body 
vibration 
therapy 
2 sessions - Spasticity NS 
Range of movement Dynamic ankle range: 
Significantly improved 
3D gait analysis Walking speed, stride 
length: Significantly 
improved 
McPherson  
et al 
1984 60 
CP: N=4 (10-18 years) Year 1: static 
stretching 
 
Year 2: 
standing 
posture 
devices 
2 years Year 1: 5 
days/week 
 
Year 2: 7 
days/week 
Knee extensor range of 
movement 
 
Knee ROM ↑ 4-9o 
Muscle tone Year 2: Decreased muscle 
tone 
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O’Dwyer et al 
1994 62 
CP: N=15 (6-19 years) Passive 
stretching 
42 days 3 days/week Ankle range of movement NS 
Contracture of triceps surae Significant decrease 
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PROPOSED FACTORS LIMITING PERFORMANCE 
 
The functional impairments seen in individuals with CP have been attributed to many 
mechanisms.  These mechanisms have been grouped into the categories of motor 
impairments, central deficits, skeletal muscle morphological changes and physical inactivity.  
These mechanisms, described below, assist in understanding the mechanisms underlying 
the functional and physical deficits seen in individuals with CP, and the effect of CP on 
human physiology, consequently increasing our understanding of the effect of exercise 
training in individuals with CP. 
 
Motor impairments and functional performance 
One of the explanations for decreased strength, speed and endurance in individuals with CP 
is the combination of motor impairments present as a result of the condition.  These include 
centrally-mediated muscular weakness, inco-ordination, spasticity, contracture and co-
activation.  Applied to running based events, these motor impairments can cause marked 
biomechanical limitation and each is described briefly below. 
 
Motor control of movement and posture has been attributed to three primary levels within the 
central nervous system, and utilises several secondary systems.  The first level of central 
control originates in the supplementary motor cortex, and controls overall movement 
strategy.  The second level lies within the sensorimotor cortex, cerebellum, basal ganglia 
and brainstem and translates the specific movement strategy into specific motor programs.  
The third level lies within the spinal cord and translates the motor programs into muscular 
activity, which is then regulated through stretch reflexes 68, 69.   
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Inco-ordination, spasticity, contracture and co-contraction are all movement irregularities 
observed in individuals where this central nervous system is disturbed or damaged in some 
way. 
 
Inco-ordination is the inability of the central nervous system to correctly utilise the proposed 
pathway to recruit motor units in the correct synchronicity to enable fluid movement 70.  In 
individuals with CP, this lack of synchronicity can result in an ungainly and awkward walking 
and running stride, due to the inability to correctly create the activation strategies and 
programs required for the execution of a regular stride. 
 
Spasticity and muscle contractures are among the most prominent features in CP, and result 
in muscles that have increased resting and dynamic tone, rigidity and decreased range of 
movement.  These muscle irregularities are a result of dysfunction, in part, of the stretch 
reflex found at the third level of the motor control hierarchy 68, 71.  Movement can be severely 
affected, as a result of these irregularities.  For example, pelvic rotation may occur due to 
hamstring muscle spasticity or compromised accuracy of foot strike due to gastrocnemius 
muscle contracture 13. 
 
Co-activation is the simultaneous contraction of antagonist muscles during contraction of the 
agonist muscle group, and is usually seen in typically developing individuals only when a 
need for increased joint stability is required, such as when walking over highly unstable 
surfaces 72.  However, co-activation during normal tasks in CP has been highlighted as one 
of the factors causing impaired performance in many tasks 15.  Two studies have shown high 
levels of co-activation and impaired performance in individuals with CP 17, 73.  This co-
activation likely has a beneficial purpose in individuals with CP, since it contributes to 
increased joint stability as a muscular strategy.  However, it also results in negative 
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outcomes for movement quality and quantity due to greater total muscle mass activation 
during movement, as well as increasing the risk of injury 54. 
 
The combination of motor impairments seen in individuals with CP would thus result in 
abnormal gait patterns, increased energy requirements for the same task conducted by an 
AB individual, as well as increased time needed to complete the task 54, 74, 75. 
 
Central deficit 
With the development of technology that allows the measurement of central drive via 
voluntary muscle activation, central mechanisms involved in the deficits observed in CP can 
now be investigated.  Stackhouse et al. (2005) superimposed electrical muscle stimulation 
during a maximum voluntary contraction in order to examine the possible central contribution 
to impaired performance, and discovered that voluntary muscle activation was 33% and 49% 
lower in the quadriceps and triceps surae, respectively, compared to AB individuals 17. 
 
This demonstrated a substantial impairment in the brain’s ability to recruit muscle, which is 
consistent with other research 18.  However, the number of motor units available to be used 
was similar, as measured by M-wave maximum muscle activation amplitudes, suggesting 
under-activation of skeletal muscle due to central inhibition 76, 77, rather than a deficit at the 
level of the muscle or motor neuron junction.  This occurs along with co-activation of 
antagonist muscles 17, leading to the theory that muscular deficits observed in individuals 
with CP are the result of a combination of muscular under-activation 19, decreased central 
input to the muscle due to damage to the supraspinal centres 78 and co-activation of agonist 
and antagonist muscles 19, 79. 
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Fatigue 
The development of muscle fatigue during exercise tasks in individuals with CP has been 
examined by few studies.  In these studies, fatigue was defined as the failure to maintain 
force output over a period of time during a set task 80.  Stackhouse et al. (2005) was the first 
to investigate fatigue characteristics of children with CP using maximal voluntary isometric 
contractions.  The authors found that the children with CP maintained force output over the 
trial compared to AB controls (42% and 52% decline in force output over the trial in CP and 
AB groups, respectively), indicating fatigue resistance in the CP group 17.  The authors 
attributed this finding to significant muscle weakness in the CP group, which resulted in the 
inability to create enough force at the beginning of the exercise trial, subsequently resulting 
in the production of less force over the trial, but for longer periods of time.  This pathological 
fatigue resistance was associated with lower agonist voluntary muscle activation and higher 
levels of agonist/antagonist co-activation.  Moreau et al. (2008), Moreau et al. (2009) and 
Eken et al. (2013) aimed to further investigate fatigue in individuals with CP using 35 
repetition maximum isokinetic dynamometry protocols 81-83.  The authors found fatigue 
resistance associated with significant muscle weakness in the children with CP compared to 
AB controls.  They further found that the observed fatigue resistance was associated with 
lower muscle voluntary activation, co-contraction of agonist and antagonist muscle groups 
and muscle atrophy of working muscle groups in the tested samples.  Interestingly, Moreau 
et al. (2008) found greater fatigue resistance with higher levels of impairment within the CP 
group, and proposed that higher levels of impairment and muscle weakness resulted in 
greater fatigue resistance in this population 81.  Thus, fatigue resistance in individuals with 
CP was closely related to muscle weakness and the adverse consequences of central 
deficit. 
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Skeletal muscle morphology 
A further contributor to the performance deficits observed in CP is altered skeletal muscle 
morphology.  Force output of a muscle is the combination of neural factors and the quality or 
nature of the muscle being activated.  Thus it stands to reason that changes in morphology 
as the result of central deficit associated with CP may impair function at the level of the 
muscle, further compounding neural factors affecting force production.  In this regard, 
several authors have attributed muscular weakness to an identified increase in Type I 
muscle fibres in lower extremity muscles in children with CP 17, 84, 85.  In addition to Type I 
muscle fibre predominance, increased intramuscular fat, atrophy and decreased muscle size 
in the paretic limbs have also been identified as an outcome of CP.  These changes have 
been consistently attributed to sustained low-frequency muscle fibre firing, caused by 
spasticity and altered central drive in muscle affected by CP 17, 21, 76, 84-87 and these findings 
indicate changes at both central and peripheral levels in individuals with CP. 
 
Physical inactivity 
The attributes and mechanistic factors discussed in this review, including strength, agility, 
aerobic endurance, central and peripheral factors, contribute to impairment of physical 
performance and functional capacity in individuals with CP.  Unsurprisingly, these factors are 
associated with physical inactivity in this population, which is perhaps of highest clinical 
importance, since it is recognised as a crucial limiting factor for the functional prognosis of 
individuals with CP. 
 
It is widely accepted that children with CP engage in less physical activity than their typically 
developing peers, with almost exclusively negative consequences 29, 88, 89.  Durstine et al. 
(2000) proposed a circular mechanism for physical inactivity in groups of individuals with 
disabilities, whereby individuals with a disability engage in less physical activity, which 
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results in deconditioning, further decreasing their level of functioning and thus volitional 
engagement in physical activity 90. 
 
This cycle is perpetuated further by psychosocial barriers to exercise, including personal and 
environmental factors such as the fear of injury or complications and the perception that the 
environment is unfriendly toward those with disabilities 91.  Lack of information about the 
benefits of physical activity as well as feelings of embarrassment or shame are also among 
the many factors that play a role in the complex interaction between psychology and 
exercise participation in individuals with disabilities 91-94. 
 
Most of the studies in the area of CP, whether in children or adults, attribute some level of 
poor performance to a relative lack of exercise training when compared to control groups.  
Engaging in physical activity, however, has been observed as one of the most important 
factors for the successful maintenance of function in this population 95.  That is, starting and 
maintaining exercise has been shown by many studies to be a mediating factor in disease 
progression 96.  Therefore, the participation of those with CP in exercise programs is 
particularly important, maybe even more so than their typically developing peers, for proper 
physiological development 41.  Despite this acknowledgement, maintenance of low levels of 
physical activity in individuals with CP, and only short duration exercise training interventions 
persist.  The improvements seen in these short duration exercise interventions, however, are 
significant enough to warrant more detailed, longer term investigations into longitudinal, high 
dose training interventions in individuals with CP from a young age. 
 
 
 
Chapter 1 
 
 
Department of Human Biology, University of Cape Town 30 
SUMMARY 
 
CP is a group of congenital neuromuscular disorders that result in reduced physical capacity.  
Research in individuals with CP has focused mainly on improving quality of life of severely 
affected and sedentary children, with little research on exercise performance capacity in 
adults and athletes with CP.  It has been established that individuals with CP: 1) present with 
a large range of deficits in exercise performance, and 2) improve significantly with 
participation in different modalities of exercise training.  However, most of the studies have 
been short in duration and predominantly investigated sedentary individuals. 
 
Through reviewing the existing literature on physiological and exercise performance deficits 
in individuals with CP, as well as investigating the possible mechanisms responsible for 
these deficits, it has become clear that, although CP has been extensively researched, there 
is no comprehensive conclusion regarding the effect of CP on human physiology.  Nor is 
there evidence for the effect of long term exercise training in these individuals.  This is 
mainly due to the use of paediatric samples, the reported physical inactivity in the study 
samples, and the relatively short interventions administered, which all act as confounding 
factors to the true effect of CP on the body.  It must be acknowledged that the grouping of 
clinical studies and sporting performance studies can make the reporting of results difficult, 
as these two groups of research prioritise different aspects of physiology.  Clinical studies 
generally prioritise health-related outcomes whereas sporting performance studies prioritise 
sporting performance and physiology.  However, due to paucity of research in the sporting 
category, the categories were grouped in an effort to understand the overall effect of CP on 
human physiology. 
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To be able to definitively describe the true effect of both CP on the body and long term 
exercise training on individuals with CP, it would be beneficial to describe individuals where 
the confounding factors of low activity status and age have been eliminated as much as 
possible.  Examining individuals who have participated in high level training over a long 
period of time would enable better identification and understanding of the physiological effect 
of CP on the body.  In-depth investigation into an athletic sample would also give insight into 
the effect of long term exercise training on the impairments observed in CP. 
 
RESEARCH QUESTIONS OF THE CURRENT THESIS 
 
The following specific research questions will be examined in the present thesis: 
 
Question 1 
What are the anthropometric, functional and fatigue characteristics of elite Paralympic 
athletes with cerebral palsy, and how do the affected and non-affected sides in these 
hemiplegic athletes compare? 
 
Question 2 
What are the physiological and neuromuscular performance characteristics of elite 
Paralympic athletes with CP compared to age matched able-bodied elite athletes? 
 
Question 3 
What are the specific fatigue profiles observed in elite Paralympic athletes with CP, and do 
they compare to the fatigue profiles reported in the literature using sedentary children with 
CP? 
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Question 4 
What are the possible explanations for the fatigue profiles seen in this elite Paralympic 
athlete cohort? 
 
Finally, this thesis will attempt to address the above-mentioned four questions with respect 
to interpretation of the findings of this thesis, and suggest clinical and coaching implications 
from these findings. 
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A description of bone mineral density and body 
composition in elite Paralympic athletes with 
cerebral palsy 
 
 
 
 
The findings of the present chapter are in review for publication as an original research 
article in the American Journal of Physical Medicine and Rehabilitation, with requested 
revisions submitted to the journal (2015) 
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INTRODUCTION 
 
Numerous developmental disorders have been associated with abnormal growth and 
restricted physical development, due to damage to one or more physiological systems at a 
young age.  Cerebral palsy (CP) affects 2.5 babies per 1000 live births and is one of the 
most common developmental disorders that affects the neuromuscular system 5.  Damage to 
the immature brain before, during or directly after birth to one of three areas of the brain that 
control movement and co-ordination, results in various physiological impairments in 
individuals with CP 6, 97. 
 
As the result of this central insult at a young age, individuals with CP are characterised by 
limb asymmetry between affected (A) and non-affected (NA) sides, shorter stature, lighter 
body mass and lower levels of bone mineral content and density than able-bodied (AB) 
controls 98, 99.  Van den Berg (1998) measured basic body composition using four-site 
skinfold measurements in 20 adolescents with CP, aged 7 - 13 years.  Whole body fat 
percentage was 18% higher in the children with CP compared to the AB controls (21.8 ± 
6.1% vs. 17.9 ± 5.0%), despite similar muscle mass between the groups 100.  Chad et al. 
(2000) compared 17 ambulant and non-ambulant individuals with CP (7.6 - 13.8 years old) to 
894 AB individuals in a paediatric database using dual-energy x-ray absorptiometry (DXA) 
total body scans 99.  Bone mineral content (BMC, a measure used in paediatric populations) 
and bone mineral density (BMD) were calculated at the proximal femur, femoral neck and in 
the total body, whilst fat mass (FM) and fat-free soft tissue mass (FFSTM) were calculated in 
the total body.  BMC Z scores, which represent age and gender matched normative values, 
were found to be 1.8 standard deviations (SD) lower in total body BMD and 3.2 SD lower in 
femoral neck BMD in individuals with CP, compared to the control group.  Interestingly, BMC 
and BMD were both lower in non-ambulant children than ambulant children with CP.  
Chapter 2 
 
 
Department of Human Biology, University of Cape Town 35 
Further, although FM was similar between CP and control groups, FFSTM was 2 SD below 
the control group, which is in alignment with the reductions observed in BMC and BMD 99. 
 
Recent studies on individuals with CP have provided evidence the contribution of non-
nutritional factors in the body composition of individuals with this condition, disputing 
previous research which attributed low BMD in children with CP to vitamin D deficiency 99, 101-
103.  These studies focused on the functional weight bearing cortical bones of the hip, which 
respond to mechanical loading.  It was proposed that the lower BMC, BMD and FFSTM 
reported in these individuals with CP were the result of low volumes of ambulation, and 
subsequent lower bone and muscle loading in these patients.  These findings supported the 
research discussed above that found that BMD was lower in non-ambulant children with CP.  
However, both ambulant and non-ambulant CP groups presented with at least 1 SD lower 
BMD and BMC compared to the control database.  This showed a residual effect of CP on 
the physiology of these individuals, despite levels of ambulation 99. 
 
The effect of mechanical loading on BMD in cortical bone is well established.  Research 
conducted on astronauts returning from long-term space travel has definitively correlated the 
lack of mechanical loading whilst in space to significant losses in BMD 104.  When 
investigating the effect of unilateral loading on BMD in athletic individuals, researchers have 
shown that BMC and BMD are significantly increased in the dominant arm of squash and 
tennis players, compared to non-dominant and control group arms 105, 106.  This increase was 
purportedly not related to isokinetic concentric strength of surrounding muscles in the arm, 
but rather the high levels of loading over long periods of time associated with racquet sports 
105.  In these studies, high BMD was negatively correlated to starting age of high level 
training, indicating that the younger the athletes started training (pre- vs. post-pubescent), 
the higher the dominant arm BMD.  This has been equated to a 22% higher humeral BMD in 
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the dominant arm (pre-pubescent starting age) compared to only 9% higher humeral BMD in 
individuals starting the sport at a post-pubescent age 107. 
 
It is therefore interesting to investigate BMD, FM and FFSTM in elite hemiplegic athletes with 
CP, who compete in Paralympic level athletics.  As discussed above, there is evidence of 
lower BMD and FFSTM in individuals with CP, which is correlated in part to lower levels of 
ambulation.  Furthermore, high levels of BMD have been associated with increased weight 
bearing load involved in continued exercise participation in AB individuals.  Therefore, 
examining a group of elite Paralympic athletes with CP who have undergone high levels of 
intensive athletic training over many years may further the understanding of the complex 
interaction between weight bearing activity, exercise and body composition in individuals 
with CP. 
 
The present study aimed to describe BMD, FM and FFSTM in six elite male Paralympic 
athletes with hemiplegic CP. 
 
METHODS 
 
Participants 
Six male elite Paralympic athletes with CP were recruited for the study (CP group, five 
participants with hypertonic CP, one participant with athetoid CP).  Ethnic distribution of the 
CP group included four white ancestry individuals, one mixed ancestry individual and one 
black ancestry individual.  All participants were track and field sprinters with hemiplegic CP, 
as diagnosed by a physician.  They all competed in track athletics at National and 
International Paralympic level.  Two of the participants were classified as T38 and four as 
T37 athletes, in accordance with the criteria established by the Cerebral Palsy International 
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Sport and Recreation Association (CPISRA) and International Paralympic Committee (IPC) 
for Paralympic competition 11, 12, 197.  T38 athletes are distinguished by limitations in running 
activities in any limb distribution, as a result of hypertonia, ataxia or athetosis while T37 
athletes present with ambulant hypertonic hemiplegic profiles, presenting with distinctive 
unilateral impairment on the affected (A) side, with a fully-functional non-affected (NA) side 
11, 12, 197.  Both T38 and T37 athletes fall into levels I to II on the Gross Motor Function 
Classification System (GMFCS) 108.  Refer to Table 2 for details.   
 
Each participant provided written informed consent prior to the study.  The study was 
approved by the University’s Human Research Ethics Committee (Ref: 156/2011). 
 
Dual Energy X-Ray Absorptiometry body scan 
Participants’ height in meters (m) and weight in kilograms (kg) was recorded on a calibrated 
scale (Seca, Model 708, Germany) and body mass index calculated as kilograms per meters 
(BMI, kg/m2) was calculated.  Both height and weight were measured while the participant 
was wearing minimal clothing, and without shoes.  BMD as well as FM and FFSTM, were 
measured using DXA total body scans (Hologic Discovery-W, software version 13.4.1, 
Hologic Bedford Inc., Bedford MA, USA).   
 
Bone mineral density 
Whole body (WB), lumbar spine (LS), femoral neck (FN) and total hip (TH) BMD was 
measured using DXA and expressed as grams per centimeter (g/cm2).  BMD Z scores, 
which represent a participants’ comparison to age and gender matched individuals in the 
DXA reference database of AB controls, were calculated by the DXA software and 
expressed as SD difference from the control database individuals.  One measurement was 
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given for WB and LS, while bilateral measurements were given for FN and TH for A and NA 
sides. 
 
Fat mass and fat free soft tissue mass 
FM and FFSTM were measured for individual upper limb (arm) and lower limb (leg) as well 
as unilateral appendicular limb distributions and expressed as kilograms (kg).  
Measurements were given for A and NA sides in the above groupings of limbs. 
 
Statistics 
All data were analysed using statistical software (Statistica 12, Statsoft Inc. Tulsa, 
Oklahoma, USA).  As this was a descriptive investigation of one group of athletes (N = 6), 
statistical analyses were not performed on whole-body total values (height, weight, BMI, WB 
BMD, LS BMD, WB BMD Z score, LS BMD Z score).  Independent t-tests were performed to 
compare differences in FN BMD, TH BMD, FN BMD Z score, TH BMD Z score, upper limb 
FM, lower limb FM, appendicular limb FM, upper limb FFSTM, lower limb FFSTM and 
appendicular limb FFSTM between A and NA sides.  Significance was accepted at P < 0.05. 
 
RESULTS 
 
Participant characteristics 
Table 2 presents descriptive characteristics of six athletes with CP with regard to class and 
level of competition, diagnosis, resting spasticity level, hemiplegic involved side and current 
100 meter (m) performance time in seconds (s) as a general overview of the current sample. 
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Table 2:  International Paralympic Committee competition classification, level of competition, 
diagnosis, resting Ashworth Scale spasticity level, involved side and current 100m sprint time of six 
participants with cerebral palsy 
 
Participant IPC 
class 
Level of 
competition 
Diagnosis Resting 
spasticity 
Involved 
side 
100 m 
time (s) 
1 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 11.54 
2  T 38 Paralympic Hypertonic 
hemiplegia 
1 – 2 Left 11.29 
3 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 12.21 
4 T 37 National Hypertonic 
hemiplegia 
1 – 2 Right 12.49 
5 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 12.6 
6 T 38 Paralympic Athetoid 
hemiplegia 
- Left 11.21 
Mean (SD) -  -  - 11.9 (0.9) 
 
Age and body composition 
Table 3 presents data for body composition, BMD, BMD Z score, FM and FFSTM.  Mean 
age for the participants was 23.3 ± 3.8 years.  Height and weight were 1.76 ± 0.03 m and 
68.59 ± 2.73 kg.  BMI was 22.14 ± 1.40 kg/m2 in this group of athletes with CP. 
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Table 3: Descriptive data of body composition, bone mineral density (BMD), bone mineral density age 
matched Z scores (BMD Z score), fat mass (FM) and fat-free soft tissue mass (FFSTM) of six 
participants with cerebral palsy.  Total scores are provided for variables as whole-body 
measurements, and unilateral values are given for affected (A) and non-affected (NA) sides.  * P < 
0.05 side main effect. 
  
 Total A NA 
Age (years) 23.3 ± 3.8   
    
Body Composition    
Height (m) 1.76 ± 0.03   
Weight (kg) 68.59 ± 2.73   
Body Mass Index (kg/m2) 22.14 ± 1.40   
    
Bone Mineral Density     
Whole body BMD (g/cm2) 1.164 ± 0.081   
Lumbar spine BMD (g/cm2) 1.117 ± 0.072   
Femoral neck BMD (g/cm2)  0.932 ± 0.124 0.979 ± 0.080 
Total hip BMD (g/cm2)  1.053 ± 0.124 1.092 ± 0.087 
    
Whole body BMD Z score -0.150 ± 0.547   
Lumbar spine BMD Z score 0.250 ± 0.672   
Femoral neck BMD Z score  0.050 ± 0.909 0.400 ± 0.626 
Total hip BMD Z score  0.133 ± 0.809 0.417 ± 0.567 
    
Fat Mass    
Upper limb FM (kg)  0.46 ± 0.14 0.42 ± 0.11 
Lower limb FM (kg)  1.58 ± 0.51 1.46 ± 0.46 
Appendicular FM (kg)  2.04 ± 0.65 1.89 ± 0.56 
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Fat-free soft tissue mass 
   
Upper limb FFSTM (kg)  2.96 ± 0.44     * 3.60 ± 0.39 
Lower limb FFSTM (kg)  8.81 ± 0.27     * 10.34 ± 0.82 
Appendicular FFSTM (kg)  11.77 ± 0.64   * 13.94 ± 1.18 
 
Bone mineral density and bone mineral density Z scores 
There were no differences between FN and TH BMD or BMD Z scores between A and NA 
sides (Table 3, Figure 1). 
 
Figure 1: Bone mineral density 
Bone mineral density (Figure 1 A) and bone mineral density age matched Z scores (Figure 1 B) for 
specific locations in the body, including whole body (WB), lumbar spine (LS), femoral neck non-
affected side (FN NA), femoral neck affected side (FN A), total hip non-affected side (TH NA) and 
total hip affected side (TH A). 
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Fat mass and fat-free soft tissue mass 
Upper limb FFSTM was significantly lower in the A side compared to the NA side (Table 3, 
Figure 2 B, 2.96 ± 0.44 kg vs. 3.60 ± 0.39 kg, P < 0.05).  Lower limb FFSTM was 
significantly lower on the A side (8.81 ± 0.27 kg for A and 10.34 ± 0.82 kg for NA, P < 0.01).  
Appendicular FFSTM was also significantly lower on the A side compared to the NA side 
(11.77 ± 0.64 kg vs. 13.94 ± 1.18 kg, P < 0.01).  There were no differences between A and 
NA FM in any limb distribution (Table 3, Figure 2 A). 
 
 
Figure 2: Fat mass and lean mass 
Fat mass (FM, Figure 2 A) and fat-free soft tissue mass (FFSTM, Figure 2 B) for specific locations in 
the body, including the upper limb non-affected side (upper limb NA), upper limb affected side (upper 
limb A), lower limb non-affected side (lower limb NA), lower limb affected side (lower limb A) and 
appendicular upper and lower limb non-affected and affected sides (appendicular NA, appendicular 
A), for unilateral FM and FFSTM distributions. * P < 0.05 side main effect. 
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DISCUSSION 
 
The present chapter was the first to describe BMD and body composition in elite Paralympic 
athletes with CP.  BMD, FM and FFSTM were measured at whole body sites, as well as at 
unilateral sites on the A and NA sides. 
 
The first important finding of this study was the similarity in FN and TH BMD and BMD Z 
scores between A and NA sides in this group of elite Paralympic athletes with CP (Table 3, 
Figure 1).  There was no difference in absolute BMD between the A and NA sides (Figure 1 
A), and although there was a tendency toward differences in BMD Z scores between the A 
and NA sides, they did not reach significance (Figure 1 B).  These findings showed that the 
BMD of this group of athletes was closely matched to that of AB individuals in the normative 
database.  Of interest and although not significantly different, BMD Z scores of the LS, FN 
and TH were above that of the age and gender matched AB individuals in the control 
database.  WB BMD was the only testing site where a lower than average Z score was 
observed. 
 
The second important finding was the difference observed in FFSTM between A and NA 
sides, despite similarities in FM between the sides (Table 3, Figure 2).  These findings were 
similar to those reported in the literature, described in the introduction of this chapter 99. 
 
Previous research has demonstrated that individuals with CP show significant reductions in 
functional capacity and exercise performance compared to AB individuals.  These deficits 
have been documented as a 30 - 73%, 15 - 42% and 27 - 46% reduction in strength, aerobic 
and anaerobic capacity, respectively 17-19, 30, 31, 31, 32, 48-50, 109, 110, which emulates the 1.8 – 3.2 
SD lower BMD Z scores observed in similar samples of individuals with CP 99. 
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However, as discussed in Chapter 1 of this thesis, the previous literature on individuals with 
CP was conducted using sedentary children.  There has been very little research conducted 
on adults with CP, and even less on adults with CP who have participated in regular physical 
activity for many years.  Thus, sedentary behaviour has been a confounding factor in the 
research conducted on the physical capacity of individuals with CP, also possibly obscuring 
the true effects of CP on the body. 
 
As such, the findings of similar BMD, BMD Z scores and FM in the present study represent 
the first descriptions of bone and body composition of elite Paralympic athletes with CP.  The 
finding of similar BMD and BMD Z scores contradict previous research which proposed that 
sedentary children with CP present with large differences in bone physiology and functional 
capacity compared to AB controls.  Furthermore, the greater than average BMD Z scores in 
the FN and TH, despite lower BMD in the rest of the body, indicates that athletes with CP 
have higher BMD in load bearing sites of the body which have a greater proportion of cortical 
bone compared to other non-loadbearing areas of the body.  As these findings emulate 
research conducted on BMD and load bearing in athletic individuals, they may provide the 
first insight into the effect of high levels of exercise training on physiology in this group of 
athletes. 
 
Similarly, the finding of comparable FM between A and NA sides provides insight into the 
effects of long term athletic training on health parameters in individuals with CP.  However, 
the finding that FFSTM was lower on the A side in this group of athletes, despite similar FM 
between sides, and which was in accordance with previous literature, provided evidence that 
there may be an upper limit of bone adaptation in individuals with CP with regard to muscle 
physiology.  That is, although bone density and FM may be highly adaptable in individuals 
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with CP, the central inhibition of muscle recruitment and neuromuscular deficits described in 
Chapter 1 may still have a large effect on muscle size, function and physiology 17, 82, 111.  This 
would result in the lower FFSTM on the A side observed in this chapter. 
 
The present study provided novel insight into the BMD, FM and FFSTM of elite Paralympic 
athletes with CP.  It is acknowledged that limitations of the research include the small 
sample size, differences in ethnic selection of the sample, lack of a control group and lack of 
longitudinal tracking of BMD.  This study was conducted in a finite group of elite athletes, 
where no more than six athletes were available to be tested, which also applies to the 
combination of four white ancestry participants, one mixed ancestry participant and one 
black ancestry participant in the sample.  However, all participants included in the study 
were male, and comparisons were made between each individual’s A and NA sides, making 
differences in ethnicity less important to the conclusions drawn from the data.  Another 
limitation of this study was the lack of an AB control group.  Further research is required 
using a longitudinal, case-controlled study to determine the effect of exercise on bone 
development and body composition in a larger sample of elite athletes with CP. 
 
CONCLUSION 
 
The present chapter offers the first novel insights into in-depth body composition of elite 
Paralympic athletes with CP.  Similar BMD and FM between A and NA sides indicates that 
high levels of athletic training over many years may have positive physiological 
consequences, including adaptation of these variables.  However, asymmetries in FFSTM 
indicated that there may be a limit to the adaptation observed in these athletes.  This study 
aimed to describe anthropometry of elite Paralympic athletes with CP.  Further studies 
investigating in-depth exercise performance and functional characteristics in a similar 
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sample of athletes with CP are required to further describe elite Paralympic athletes with CP, 
which will be the focus of work described in the next three chapters of this thesis. 
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A description of sprint cycling performance and 
neuromuscular characteristics in elite Paralympic 
athletes with cerebral palsy 
 
 
 
 
The findings of the present chapter have been published as an original research article in the 
American Journal of Physical Medicine and Rehabilitation, 94: 28-37 (2015) 
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INTRODUCTION 
 
As discussed in detail in Chapter 1 of this thesis, several studies using paediatric 
participants with cerebral palsy (CP) have described marked impairments in exercise 
performance in this population.  Isometric strength 17 and sprint running speed 48 have been 
found to be 39% to 56% lower in individuals with CP than able-bodied (AB) controls.  Deficits 
ranging between two and four standard deviations have been found in anaerobic 
performance of children with CP when compared to performance of age and activity 
matched individuals without CP using the Wingate sprint cycle test 49, 112.  Furthermore, 
Verschuren et al. (2010) found that aerobic endurance performance (VO2peak) was 15% 
lower in individuals with CP, when using a progressive maximal treadmill test 29. 
 
There is evidence that regular physical training has functional benefits in children with CP.  
Exercise intervention studies using sedentary, paediatric samples have found dramatic 
improvements in strength, aerobic capacity and anaerobic capacity in both diplegic and 
hemiplegic groups, with as little as six weeks of training 19, 51, 65.  Elite athletes with and 
without disabilities train at very high volumes for many years in order to compete at Olympic 
or Paralympic level.  As no exercise performance research exists on this athletic calibre of 
individual with CP, it is intriguing to consider whether elite training status in individuals with 
CP alters factors that contribute to performance, compared to AB individuals.  These factors 
include fatigue profiles, peak power output capacity and neuromuscular activation.  A 
comparison between athletes with CP and AB athletes would improve understanding of the 
true effects of CP, whilst eliminating the effects of sedentary behaviour on the results. 
 
Therefore, the aim of this study was to describe sprint cycle performance and neuromuscular 
characteristics of elite Paralympic athletes with CP during a maximal cycling trial, compared 
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to well-trained, running sprint performance matched AB athletes.  The athletes with CP were 
internationally competitive track and field athletes, who have trained for between six and 20 
hours per week over many years.  Power output, muscle activation and fatigue 
characteristics, as well as the presence of neuromuscular irregularities were investigated 
between the groups.  It was hypothesised that the athletes with CP would perform the 
Wingate sprint cycle test at a significantly lower power output that the AB athletes, and 
would show a flatter fatigue profile in power output over the course of the test.  It was further 
hypothesized that the lower power output would be associated with a significantly lower level 
of muscle activation, as measured by electromyography (EMG).  This would be in keeping 
with the published literature in untrained and paediatric individuals with CP. 
 
METHODS 
 
Participants 
Five male elite athletes with hypertonic hemiplegic CP (CP group) and 16 male well trained 
AB controls (AB group) were recruited for the study.  The participants in the CP group were 
all track sprinters with hemiplegic CP, as diagnosed by a physician.  They all competed at 
International Paralympic level.  Three of the participants were classified as T38 and two as 
T37 athletes, in accordance with the criteria established by the CPISRA and IPC for 
Paralympic competition 11, 12, 197.  T38 athletes are distinguished by limitations in running 
activities in any limb distribution, as a result of hypertonia, ataxia or athetosis.  T37 athletes 
are classified as having ambulant hypertonic hemiplegic profiles and present with distinctive 
hemiplegic limitations, with a fully-functional non-affected side.  Both T38 and T37 athletes 
present with grade 1 to 2 spasticity on the Modified Ashworth Scale, which indicates a mild 
to moderate level of resting spasticity in the affected limbs 12.  Both T38 and T37 athletes fall 
into levels I to II on the Gross Motor Function Classification System (GMFCS) 108.  In terms 
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of athletic performance, T38 and T37 athletes are approximately 14% and 22% slower 
compared to AB 100m and 200m world record sprint performances (unpublished 
observations). 
 
AB participants were selected from rugby, cricket and hockey teams, and were additionally 
selected only if they played in positions where sprint ability was an important attribute for 
performance.  They competed from club to International level. 
 
All participants were unaccustomed to leg cycling exercise, as their main form of exercise 
was running based sprint exercise.  Cycling was used as a modality as the Wingate sprint 
cycle test is a validated method for assessing sprint performance, and allows the capture of 
data at a high sampling rate.  The use of the Wingate sprint cycle test minimized the effect of 
experience of cycling on performance in either group. 
 
General Overview of Testing 
Participants reported to the laboratory on one occasion.  Their height in meters (m) and body 
mass in kilograms (kg) were measured on calibrated equipment (Seca, Model 708, 
Germany).  Body mass index (BMI) was calculated as kilograms per meter (kg/m2).  
Participants performed a 10 second sprint test, adapted from the standard 30 second 
Wingate sprint cycle test.  Following this, participants rested for 15 minutes, and then 
performed a traditional 30 second Wingate sprint cycle test (WIN30).  The 10 second sprint 
was used to ensure a maximal effort in WIN30 through a comparison of the first 10 seconds 
power output of both tests.  It was also used for normalisation of the EMG signal recorded 
during WIN30.  Bilateral EMG of five muscles was measured during both tests.  The specific 
details of these measurements are described subsequently. 
 
Chapter 3 
 
 
Department of Human Biology, University of Cape Town 51 
Each participant provided written informed consent prior to the study.  The study was 
approved by the University’s Human Research Ethics Committee (Ref: 156/2011). 
 
Wingate Anaerobic Sprint Cycle Test 
The WIN30 was performed using an electromagnetically braked cycle ergometer (Velotron 
Dynafit Pro, Racermate Inc., Seattle, WA, USA).  This test has been validated in many 
populations, including individuals with CP and has an Interclass Correlation Coefficient of 
0.95 in trained and non-trained individuals with CP 113, 114.  A standardised warm up 
comprised cycling at a constant workload of 1.5 watts per kilogram (W/kg) at a self-selected 
cadence for five minutes, followed by a two-minute rest period before commencement of the 
10 second sprint.  Upon completion of the sprint a break of 15 minutes, WIN30 was 
performed.  For standardisation in both the sprint and WIN30, the participants were given 20 
seconds to reach 100 revolutions per minute (RPM) and then were instructed to maintain 
100 RPM for 10 seconds, after which time a load of 0.075 kilogram/kilogram body mass 
(kg/kg BM) body mass was applied, commencing the test.  Participants were instructed to 
pedal as hard and as fast as they could against the resistance for the set period of time (10 
or 30 seconds).  They were instructed to remain in a seated position throughout the test.  
Power output was expressed relative to body mass (W/kg). 
 
Fatigue Index 
The fatigue index (FI) was calculated as the highest power output (W/kg) achieved during 
the test minus the power output (W/kg) achieved in the final second of the test.  This was 
divided by the peak power.  The FI was expressed as a percentage (%). 
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Electromyography 
Amplitude 
Muscle activity (EMG) of five muscles, namely erector spinae (ES), gluteus medius (GM), 
biceps femoris (BF), vastus lateralis (VLO) and gastrocnemius (GC), was recorded in both 
legs using a telemetric EMG system (Telemyo GT2400 G2, Noraxon, USA Inc, Arizona, 
USA), to allow comparison of affected (A) and non-affected (NA) sides in the participants 
with CP.  In the CP group, A and NA sides corresponded to their own non-dominant (ND) 
and dominant (D) sides.  In the AB group, the ND and D sides were similarly compared to, 
and expressed as, the CP group’s A and NA sides.  Dominance was self-reported.  Prior to 
the placement of the electrodes, the area was shaved and cleaned with ethanol.  Two 
electrodes with a 20 millimeter inter-electrode distance (Blue Sensor, Medicotest, Denmark) 
were placed over the muscle belly whilst a reference electrode was placed on the anterior 
superior iliac spine of the right leg.  Placement was in accordance with Surface 
Electromyography for the Non-Invasive Assessment of Muscle (SENIAM ) recommendations 
115.  As with previous research using EMG during cycling, each test was divided into five 
second epochs for processing and analysis 116-118.  For analysis of the EMG signal, the raw 
EMG signals were band passed filtered between 20 and 500 Hertz (Hz).  All signals were 
rectified and smoothed using root mean square analysis for a 50 millisecond time window. 
 
The EMG in WIN30 was normalised to the highest mean amplitude five second period of the 
10 second sprint.  The use of a 10 second sprint for EMG normalisation establishes a 
constant baseline of EMG activity to which all subsequent activity is compared and 
expressed as a percentage.  This has been shown to be a valid method of normalization for 
dynamic exercise 119.  To ensure reliable EMG data reporting, EMG was measured in a 
rested state as well as during manual isolation of every muscle.  This ensured that the 
signals recorded were not artefacts of incorrect placement, movement or noise generated by 
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external variables.  Mean normalised amplitude of the five second periods as well as 
individual root-mean-squared EMG signals to identify irregularities were analysed. 
 
Frequency 
Median frequency spectral analysis of the first and last five second periods of WIN30 was 
analysed using a Fast Fourier Transform algorithm.  EMG frequency is the rate at which 
action potentials are sent to the working muscles from the central nervous system.  Higher 
median frequencies are a mechanism of muscular force summation (higher force), while a 
change in frequency indicates a change in the type of muscle fibers activated, and ultimately 
fatigue 120, 121.  The analysis was performed to compare frequency between non-fatigued 
states (PRE, in the first five seconds of the test) and fatigued states (POST, in the last five 
seconds of the test).  The frequency analyses were between 5 - 500 Hz, as EMG signal 
outside this range contains mostly noise and unusable signal 122.  As fatigue was of interest, 
the change from PRE to POST is reported. 
 
Statistical Analysis 
Power output and EMG were averaged over one and five second periods, respectively.  All 
data were analysed using statistical software (Statistica 10, Statsoft Inc. Tulsa, Oklahoma, 
USA).  Significance was accepted at a P value <0.05.  Intragroup comparisons between A 
and NA sides, as well as change over time between the groups were performed using a 
three way repeated measures analyses of variance ANOVA (Time x Side x Group 
interaction) for all data sets.  Descriptive data of the two groups were compared using 
independent t-tests. 
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RESULTS 
 
Participants 
Table 4 shows descriptive characteristics of the CP, which comprised five elite Paralympic 
athletes with CP.  The groups were matched for age (21.6 ± 4.2 and 23.4 ± 3.0 years, CP 
and AB, respectively) and current 100 meter running sprint performance (12.2 ± 0.9 and 12.3 
± 1.1 seconds, for CP and AB, respectively).  However, the AB participants were significantly 
heavier than the CP group (BMI of 25.9 ± 2.4 kg/m2 vs. 21.1 ± 1.4 kg/m2).   
 
Table 4:  International Paralympic Committee competition classification, level of competition, 
diagnosis, resting Ashworth Scale spasticity level, involved side and current 100m sprint time in 
seconds of six participants with cerebral palsy 
 
Participant IPC 
class 
Level of 
competition 
Diagnosis Resting 
spasticity 
Involved 
side 
100m 
time (s) 
1 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 12.3 
2 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Left 11.2 
3 T 38 National Hypertonic 
hemiplegia 
1 – 2 Right 13.5 
4 T 38 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 11.9 
5 T 38 Paralympic Hypertonic 
hemiplegia 
1 – 2 Left 12.2 
Mean (SD)      12.2 (0.9) 
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Wingate Anaerobic Sprint Cycle Test 
Peak power output during WIN30 was 10.4 ± 0.5 and 9.8 ± 0.5 W/kg for AB and CP groups 
respectively (P < 0.05), and occurred at 10 seconds in both groups (Figure 3).  Power output 
was significantly higher in AB throughout the trial (P < 0.05). 
 
Power output declined similarly between groups, with the FI of the AB and CP groups 
calculated as 27 ± 6.9 % and 25 ± 7.3 %, respectively. 
 
 
Figure 3:  Power output (W/kg) of 30 second Wingate sprint cycle test over 30 seconds (s) for the 
able-bodied group (solid triangle) and cerebral palsy group (open square), with peak in both groups at 
10 seconds. * P<0.05, time and group effect. 
 
Electromyography 
Amplitude 
Figure 4 A - E shows normalized EMG activity as percentage maximum activation (% max) 
on the A and NA sides of the five measured muscles in the CP group (left panels) and AB 
group (right panels).  There were no differences in mean muscle activity over time between 
A and NA sides, nor between AB and CP groups.  In four muscle groups (ES, Figure 4 A; 
Glut, Figure 4 B; BF, Figure 4 C; GC, Figure 4 E), EMG amplitude decreased significantly 
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over the trial in both limbs, and in both CP and AB groups (P < 0.001).  In both the CP and 
AB groups, VLO activity remained unchanged over time (Figure 4 D). 
 
 
Figure 4:  Normalised muscle activation over a 30 second Wingate sprint cycle test for affected (A) 
and non-affected (NA) sides of the cerebral palsy group (left panel) and correlating non-dominant and 
dominant sides of the able-bodied group (right panel) for erector spinae (Figure 4 A), gluteus medius 
(Figure 4 B), biceps femoris (Figure 4 C), vastus lateralis (Figure 4 D) and gastrocnemius (Figure 4 
E). * P<0.05 time effect. 
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Frequency 
Median frequency decreased significantly in both AB and CP groups, on both the A and NA 
sides (Table 5, P < 0.05).  Median frequency decreased significantly more from PRE to 
POST in VLO on the A side of the CP group compared to the AB group (P < 0.05).  
 
Table 5:  Percentage decrease in median frequency from pre-fatigued (PRE) to post-fatigues (POST) 
states for affected (A) and non-affected (NA) sides of muscle activation in the cerebral palsy group 
(left column) and correlating non-dominant (ND) and dominant (D) sides in the able-bodied group 
(right column).  *P<0.05 time effect; #P<0.05, side and time and group effect 
 
 CP AB 
Muscle A NA ND D 
Erector spinae 17.16 % * 10.08 % * 20.99 % * 7.03 % * 
Gluteus medius 15.10 % * 11.42 % * 3.08 % * 5.17 % * 
Biceps femoris 20.24 % * 15.68 % * 8.54 % * 7.41 % * 
Vastus lateralis 13.35 % # 12.68 % * 8.48 % * 13.10 % * 
Gastrocnemius 6.91 %  * 10.48 % * 14.67 % * 7.45 % * 
 
Individual EMG Trace Patterns 
Figure 5 A shows bilateral co-activation of the stabilising ES muscles on each pedal stroke in 
an AB participant during WIN30.  The pedal stroke is identified by VLO activation in the 
bottom trace of the panel, with the top trace depicting ES activation.  Figure 5 B depicts an 
atypical firing pattern of the ES observed in a participant with CP.  ES activity occurs during 
the pedal stroke on the NA pedal stroke only, with no activity during the A side’s pedal 
stroke. 
Chapter 3 
 
 
Department of Human Biology, University of Cape Town 58 
 
Figure 5:  Muscle activation irregularities in stabilising muscles in cerebral palsy.  Typical firing 
pattern of the erector spinae in an able-bodied athlete (Figure 5 A) with a lack of required co-
activation of the erector spinae is observed in a participant with cerebral palsy (Figure 5 B). 
 
Figure 6 A shows a typical firing pattern of two power producing muscles (BF and VLO) in an 
AB participant, which reciprocally activate per pedal stroke.  Figure 6 B shows the same 
muscle traces of a participant with CP.  BF activation on both sides increases when the A 
side pedal stroke occurs.  On the NA side, there is significantly less BF activation.  Figure 6 
C displays continuous activation of BF muscles of both the A and NA sides, with typical firing 
patterns of the VLO muscle. 
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Figure 6: Muscle activation irregularities in power-producing muscles in cerebral palsy.  Typical firing 
pattern of vastus lateralis (VLO) and biceps femoris (BF) in an able-bodied athlete (Figure 6 A) in the 
first five second epoch of 30 second Wingate sprint cycle test (non-fatigued state).  Co-activation of 
the BF and VLO (Figure 6 B) and atypical motor drive of the BF (Figure 6 C) observed in two 
participants with cerebral palsy. 
 
 
 
 
Chapter 3 
 
 
Department of Human Biology, University of Cape Town 60 
DISCUSSION 
 
The present study compared elite Paralympic athletes with CP to age and 100m sprint 
performance matched AB athletes, in a fatiguing maximal cycling task.  Based on previous 
literature, it was initially hypothesised that individuals with CP would present with 
significantly lower power outputs and muscle activation levels, as well as display less 
attenuation of these parameters with fatigue during a maximal sprint trial.  It was found in the 
present study that the AB athletes produce higher power output throughout WIN30 
compared to the CP group (Figure 3), but that all other aspects of performance, including FI 
and muscle activation levels, were similar between groups.  These findings provide the first 
exercise performance based evidence showing that athletes with CP may have overcome 
previously documented deficits in performance and neuromuscular activation. 
 
FI was similar between groups, demonstrating a similar decline in power output from peak 
value, measured at similar time points in CP and AB (Figure 3).  Associated mean EMG 
changed similarly over the trial in all measured muscle groups (Figure 4).  Furthermore, 
changes in EMG over the trial were similar between A and NA sides in the CP group and 
corresponding ND and D sides in the AB group. 
 
The existing literature suggests that individuals with similar forms of CP to the current 
sample (GMFCS levels I and II) exhibit lower levels of neuromuscular fatigue as a result of 
sub-optimal central drive, and the consequent inability to produce enough isokinetic torque 
to create fatigue 17, 81, 123.  This muscle weakness has been attributed to multiple factors 
including spasticity, co-activation, Type I muscle fibre predominance and intramuscular 
weakness 124-127.  The findings of the current study suggest that despite a relative weakness 
in the CP group, demonstrated by lower power outputs in the Wingate sprint cycle test (10.4 
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± 0.5 W/kg and 9.8 ± 0.5 W/kg for AB and CP respectively, P < 0.05), the associated lower 
neuromuscular fatigue shown by literature was not present in this elite athletic sample.  This 
was demonstrated by the similarity in FI and progressive decrease in EMG activity over the 
trial between AB and CP groups in all five muscles tested (P < 0.05). 
 
These results may be the effect of long term, high level athletic training, as first proposed in 
Chapter 2 of the current thesis.  Research to date which show deficits in performance and 
flattened fatigue profiles in CP, has been performed on sedentary children 128.  However, 
marked changes in muscular adaptation have been observed with exercise training in these 
samples, making it clear that there is capacity to significantly improve exercise performance 
and functional capacity in individuals with CP 19, 51, 65.  Therefore, with the findings of the 
present chapter, the current sample of elite Paralympic athletes may represent a group of 
individuals with CP that have reached near-maximal muscular adaptation.   
 
This adaptation may include the possible movement away from Type I muscle fibre 
predominance and muscular weakness.  This explains the similar fatigue profiles seen 
between groups (FI of 27 ± 6.9 % and 25 ± 7.3 % for AB and CP groups, respectively, Figure 
3) and a greater peak power output achieved in the CP group compared to previously 
published power values for soccer and cycling non elite athletes with CP (9.8 W/kg in this 
study vs. 8.3 W/kg reported in previous literature) 114.  Frequency analysis of the EMG signal 
further support that the CP and AB groups fatigued similarly, as frequency shifts were similar 
between the groups.  The observed changes, a shift from higher to lower frequencies, is 
typical of a shift from Type II muscle fibre activation to Type I fibre activation, due to fatigue 
of the fast-twitch power-producing fibres 129.  The similarity in frequency decline in both the 
CP and AB groups may further support the hypotheses of 1) a higher proportion of and 2) a 
higher utilisation of Type II muscle fibres in this sample of elite athletes with CP 129, 130.  A 
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significantly greater reduction in frequency occurred in the CP group’s A side VLO (the 
primary power producing muscle), further suggesting the utilization of Type II muscle fibres. 
 
It may be argued that the similarities in physiology observed between the groups may be the 
result of the current sample of athletes consisting athletes in classes T37 and T38, 
representing a group of individuals with milder forms of CP.  It is believed that this is not the 
primary origin of the results of the present chapter, as only reference to previous studies 
conducted using individuals in GMFCS levels I to II was made, which were comparable to 
the level of impairment in the current sample of athletes with CP.  The possibility of this 
contributing factor, however, cannot be disregarded. 
 
The second important finding was the presence of CP-associated neuromuscular 
irregularities identified in the athletes with CP during the WIN30, in both stabilising (ES 
muscles, Figure 5) and power (VLO and BF muscles, Figure 6) muscles, despite the 
similarities in fatigue between the CP and AB groups.  Figure 5 shows co-activation of both 
ES muscles on the NA side’s pedal stroke and complete lack of activation on the A side’s 
pedal stroke of an athlete with CP (Figure 5 B).  The existing theory on the role of the 
stabilising ES muscles during locomotion is that the ES muscles bilaterally co-activate with 
heel strike in walking / pedal stroke in cycling to counteract unwanted trunk movement 131, 
132.  These muscles also, in conjunction with other lower back muscles, balance external 
loads to decrease forces on the spine which, when disrupted, leads to injury 133, 134.  Thus the 
lack of firing on the CP body’s A side may impair the stability required for that side’s pedal 
stroke, and predispose this athlete to injury. 
 
Furthermore, neuromuscular irregularities in power muscles (Figure 6) may have an impact 
on injury incidence, as well as overall performance 54, 79.  Figure 6 A demonstrates typical BF 
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and VLO activity in an AB participant.  VLO and BF are active in a reciprocal manner, 
ensuring that the application of downward force to the pedal is timed appropriately during the 
upstroke.  Figure 6 B demonstrates co-activation of the agonist (VLO) and antagonist (BF) 
muscles on the A side, with a lack of activation on the NA side, where it is also required for 
correct pedal power production.  It has been proposed that bi-articular muscles, including the 
BF, are involved in the control of the direction of force application on the pedal during cycling 
135, therefore co-activation may produce counter-acting torques on each pedal stroke.  That 
is, firing of the BF on the downward portion of the pedal stroke may have exerted opposite 
forces to the VLO, which would result in both forces being exerted on the pedal 
simultaneously with a consequent loss of economy.  The observed co-activation of this 
antagonist pair, however, may also be an activation strategy required for increased joint 
stability on the A side, by equalising articular movement and pressure during force 
application 136-138.  Furthermore Figure 6 C displays continuous activation of BF muscles of 
both the A and NA legs despite typical firing patterns of the VLO muscle, indicating an 
atypical motor drive to that muscle group 76.  The complete lack of coherent firing patterns 
may lead to a lack of co-ordinated power production for both the A and NA sides, which 
would result in a reduction of power output.  There may also be an increased risk of injury 
due to compensation by the antagonist muscle groups, which has been shown to be a major 
risk factor for muscle injuries in runners 139, 140. 
 
The present study has provided the first description of elite Paralympic athletes with CP 
compared to AB athletes.  It has identified interesting findings in an as yet unstudied sample, 
but with certain limitations.  Stroke-by-stroke bilateral power output on the cycle ergometer 
was not measured, a measurement that would have proved very useful in identifying 
neuromuscular differences between sides.  The use of M-wave muscle stimulation would 
have also allowed for absolute amplitude EMG activation comparisons between sides, and is 
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advised for future studies in this area.  Finally, it would have been ideal to be able to conduct 
fibre typing via biopsy in the athletes, which would support the initial hypothesis, but the 
expensive and invasive nature of the test needs to be taken into consideration.  Future 
studies are required during running exercise, which would be applicable to the athletes’ 
training preference. 
 
CONCLUSION 
 
The present chapter described performance and neuromuscular characteristics of elite 
Paralympic athletes with CP during maximal sprint cycling.  The similarity in FI and 
neuromuscular fatigue between the CP and AB groups indicates that the current sample of 
elite athletes with CP may have a different physiology to previously studied untrained 
individuals with CP.  It was proposed that this movement toward AB levels of physiology may 
be a result of high level training over many years.  This may have both empirical and clinical 
application, as it may indicate the upper-most ability of the cerebral-palsied body to adapt 
toward typically-developed levels of physiology.  Further research, however, is required to 
either support or refute the performance and fatigue findings of the current study.  Chapter 4 
aims to test the findings of the present chapter, through additional exploration into exercise 
performance and fatigue in athletes with CP. 
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CHAPTER 4 
CHAPTER 4 - The effects of induced volitional fatigue on sprint and jump performance 
in elite Paralympic athletes with cerebral palsy 
The effects of induced volitional fatigue on sprint 
and jump performance in elite Paralympic athletes 
with cerebral palsy 
 
 
 
 
The findings of the present chapter have been accepted for publication as an original 
research article in the American Journal of Physical Medicine and Rehabilitation (2015) 
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INTRODUCTION 
 
Complex regulation of both central and peripheral physiological factors is important for 
maximal exercise performance.  This complex regulation allows the body to perform at peak 
capacity, while preventing potentially adverse perturbations in homeostasis 80, 141.  Fatigue, 
or failure to maintain expected force output, in both clinical and athletic populations, has 
therefore been a topic of interest for many years. 
 
Studies of fatigue in individuals with cerebral palsy (CP) have been made difficult to interpret 
by differences in methods used to measure fatigue.  One method used to measure fatigue is 
the determination of decline in force output during repeated maximal contractions.  Using 
this method, individuals with CP have been shown to maintain force output for longer than 
able-bodied (AB) controls 17, 81, 82, suggesting greater fatigue resistance.  Similarly, when the 
participants in these studies were graded into the various levels of the Gross Motor Function 
Classification System (GMFCS), it was found that the participants in the higher levels (lower 
functional capacity) showed a greater fatigue resistance than those in the lower levels 
(higher functional capacity).  It was thus demonstrated that greater fatigue resistance was 
observed in participants with greater impairment, at least when this definition of fatigue is 
used 81. 
 
However, this method of measurement of the rate of decline of force output may be 
confounded by the inability of individuals with CP to generate high force output at the onset 
of exercise, which results in a flatter fatigue profile compared to AB individuals.  Fatigue 
resistance may thus be a misleading term when applied to a population with CP, as fatigue 
profiles are strongly influenced by the ability of an individual to generate high initial 
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workrates, and subsequently the observed fatigue resistance was a direct result of muscle 
weakness in these individuals 142, 143. 
 
It has been postulated that the muscle weakness observed in individuals with CP is due to 
the effect of primary central damage which negatively influences motor unit recruitment 17, 
and induces secondary changes at the level of the skeletal muscle 82.  This would account 
for the reduced initial force output produced by individuals with CP, since it would be present 
even in the absence of fatigue.  Furthermore, co-activation of agonist and antagonist 
muscles, and subsequent incoordination of movement, are also factors to be considered in 
the reduced force output observed in individuals with CP 82.  It is important to note that the 
abovementioned findings were described during assessment of isokinetic dynamometry, and 
therefore functional weakness may be more apparent during more complex tasks involving 
the greater integration of muscle groups, as would occur during running.  
 
It has been shown in Chapter 3 of this thesis that during sprint cycling exercise, elite 
Paralympic athletes with CP do not display the fatigue resistance observed in studies using 
young sedentary individuals.  Indeed, similar fatigue profiles during a 30 second Wingate 
sprint cycle test were observed in athletic adult individuals with CP, compared to AB 
controls, despite a lower power output throughout the test in the CP group.  Certain other 
central irregularities were documented, including co-activation of agonist and antagonist 
muscles, lack of correct firing patterns in stabilising and power producing muscles and 
atypical motor drive.  It was proposed that the similar time course changes in performance in 
athletes with CP was the consequence of their ability to produce a comparable initial power 
output to AB controls (only 10% lower, compared to 30 - 50% deficit observed in sedentary 
individuals in previous research), which perhaps could be attributed to long term, elite level 
athletic training.  A limitation of Chapter 3 was that cycling exercise was used to evaluate 
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fatigue in athletes who are predominantly sprint runners.  This study therefore aimed to 
investigate performance, fatigue and neuromuscular activation during maximal explosive 
exercise in elite Paralympic athletes with CP, compared to well trained, sprint specific AB 
athletes.  Specifically, sprint performance, maximal jump performance and muscle activation 
were investigated before and after a bout of exercise to exhaustion. 
 
Therefore, based on the findings of Chapter 3, it was hypothesized that the athletes with CP 
would show reduced performance in the sprint and jump tests, but would display a similar 
reduction in performance as a result of the prior fatiguing bout of exercise, compared to 
controls.  It was further hypothesized that a similar reduction in performance would be 
associated with changes in muscle activation, measured by electromyography (EMG). 
 
METHODS 
 
Participants 
Eighteen male athletes were recruited for this study, comprising six athletes with hemiplegic 
CP (CP group) and 12 well trained AB controls (AB group). 
 
The CP group consisted of Paralympic level track sprinters and had trained between 14 and 
20 hours per week for between one and 10 years.  All athletes presented with hemiplegic 
CP, as diagnosed by a physician.  Two athletes were classified as T38 athletes and four 
were classified as T37 athletes.  T38 athletes are classified as having functional limitations in 
function in any limb distribution, resulting from hypertonia, ataxia, or athetosis, as designated 
by the CPISRA and the IPC 11, 12, 197.  In addition, T37 athletes are classified as having  
ambulant hemiplegic profiles, usually presenting with a hypertonic affected (A) side, and full-
functioning non-affected (NA) side 12.  Both T38 and T37 classes present with grade 1 to 2 
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on the Modified Ashworth Scale, which indicates a mild to moderate level of resting 
spasticity in the A limbs 144 and were classified as level I of the Gross Motor Function 
Classification System (GMFCS) 108. 
 
The AB participants were selected from National and Olympic men’s field hockey squad if 
they played in positions where sprint ability was an important attribute for performance 
(midfielders, strikers). 
 
General Overview of Testing 
Participants reported to the laboratory on two occasions.  The first visit was used as a 
familiarization trial.  On the second visit, their height in meters (m) and body mass in 
kilograms (kg) were measured using calibrated equipment (Seca, Model 708, Germany).  
After an adequate self-selected warm up, participants performed one 40m Sprint test (40m 
ST), followed by two Vertical Jump tests off both legs (VJ-B), and two Vertical Jump tests off 
the (A, VJ-A) and (NA, VJ-NA) legs respectively.  The participants were then required to 
complete a modified Multistage Shuttle Run Test (MSRT) to exhaustion.  This was used to 
induce maximal fatigue.  Within a minute of completion of the MSRT, participants repeated 
the 40m ST, VJ-B, VJ-A and VJ-NA test protocol, to assess changes from a pre-fatigued 
(PRE) state to a post-fatigued (POST) state.  Bilateral muscle activity (EMG) of five muscles 
was measured during the 40m ST, VJ-B, VJ-A and VJ-NA.  The specific details of these 
methodologies are described subsequently. 
 
Each participant provided written informed consent prior to the study.  The study was 
approved by the University’s Human Research Ethics Committee (Ref: 156/2011). 
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40m Sprint Test 
The 40m ST was performed using an indoor track and SmartSpeed timing gates 
(FusionSport, Grabba International Pty Ltd, Queensland, AUS).  The 40m ST is a validated 
test used to measure running performance over short distances 145.  Starting from a 
crouched position, participants were instructed to run as fast as possible down a straight 
40m track, only decelerating after passing the last timing gate.  Total 40m time was recorded 
in seconds (s). 
 
Vertical Jump Test 
Vertical Jump (both legs) 
The Vertical Jump Test, a validated test for the assessment of lower limb muscle power 146, 
was performed using a Vertec Vertical Jump Stand (Sports Imports, Hilliard, Ohio, USA).  
Before testing commenced, participants were required to touch the stand as high as possible 
with their dominant arm stretching vertically above their head, but with their heels on the 
ground, eliminating the effect of participant maximum height on final results.  Participants 
were instructed to jump as high as possible off both legs (VJ-B), from a standing position, 
hitting the highest point on the stand with their dominant hand.  No arm swinging was 
permitted and only one knee bend was permitted.  The final result was height jumped in 
centimeters (cm). 
 
Vertical Jump (affected and non-affected legs) 
Vertical Jump Tests were performed on the affected (VJ-A) and non-affected (VJ-NA) legs 
individually.  Both the A and NA legs in the CP group were matched to non-dominant (ND) 
and dominant (D) legs in the AB group, respectively.  The CP group’s A and NA sides also 
corresponded to their own ND and D sides.  Dominance was self-reported.  Using the same 
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equipment as described above, participants were instructed to jump as high as possible off a 
single leg (either A or NA) after a two step walk in onto the jumping leg. 
 
Two attempts at each jump were taken (VJ-B, VJ-A, VJ-NA), with the highest jump in cm 
recorded. 
 
Multistage Shuttle Run Test 
An adapted MSRT was completed to exhaustion.  Based on the standard MSRT, 
participants ran between two lines 20m apart, to an externally paced audible signal, until 
they were unable to continue at the pace of the test.  The initial running speed corresponded 
to shuttle 82 (level 10) on the standard validated MSRT, as sprint endurance was the main 
outcome of the test 147.  Since the ability to stop suddenly and change direction is limited in 
athletes with CP, the standard test was adapted.  Thus, participants ran one shuttle, followed 
by a short rest period (corresponding to the duration of the following shuttle), before 
resuming running.  Ratings of perceived exertion (RPE, scale units) and heart rate in beats 
per minute (HR, bpm) were recorded at the end of every level reached.  Total number of 
shuttles was recorded at termination of the test as a measure of volitional fatigue between 
the groups. 
 
Electromyography 
Amplitude 
EMG activity of five muscles, namely erector spinae (ES), gluteus medius (GM), biceps 
femoris (BF), vastus lateralis (VLO) and gastrocnemius (GC) was recorded from both legs 
using a telemetric EMG system (GT2400 G2, Noraxon, USA Inc, Arizona, USA).  This 
allowed comparison between A and NA sides in the participants with CP (which 
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corresponded to their own ND and D sides, respectively).  In the AB group, the ND and D 
legs were similarly compared.   
 
Prior to the placement of the electrodes, the area was shaved and cleaned with ethanol.  
Two electrodes with 20 millimeter inter-electrode distance (Blue Sensor, Medicotest, 
Denmark) were placed over the muscle belly whilst a reference electrode was placed on the 
anterior superior iliac spine of the right leg.  Placement was in accordance with Surface 
Electromyography for the Non-Invasive Assessment of Muscle (SENIAM) recommendations 
115, and the electrodes were not removed at any stage of the testing protocol.  To ensure 
reliable EMG data reporting, EMG was measured in a rested state as well as during isolated 
contraction of every muscle.  This ensured that the signals recorded were not artefacts of 
incorrect placement, movement or noise generated by external variables.  For analysis of the 
EMG signal, the raw EMG signals were band passed filtered between 20 and 500 Hertz 
(Hz).  All signals were rectified and smoothed using root mean square analysis for a 50 
millisecond window 148. 
 
For the 40m ST, EMG was analysed as mean muscle activity per second.  The sampling 
period began after four strides, and was measured for a period of three seconds thereafter.  
For the VJ-B, VJ-A and VJ-NA, the sampling period began at the visible onset of muscle 
activation of the jumping leg’s VLO muscle, and was measured in all muscles for the entire 
period of that VLO’s muscle activation.  All EMG in the 40m ST, VJ-B, VJ-A and VJ-NA was 
normalised to maximum muscle activation achieved the first three seconds of the first 40m 
ST.  This was performed as the first three seconds represented the highest measured 
muscle activation.  EMG was expressed as percentage maximum activation (% max). 
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EMG frequency was not reported in this chapter, as frequency is not a reliable measure of 
fatigue during dynamic exercise, and is used mainly in static or cycling exercise. 
 
Statistical Analysis 
All data were analysed using statistical software (Statistica 12, Statsoft Inc. Tulsa, 
Oklahoma, USA).  Significance was accepted at a P value < 0.05.  Comparisons of sprint 
performance and jump height between A and NA sides, as well as fatigue-induced changes 
between groups and sides were performed using a three way repeated measures analyses 
of variance ANOVA (Time x Side x Group interaction).  Magnitude-based inferences of 
change (effect size) were calculated between PRE and POST 40m ST in both groups, 
according to Cohen’s d.  A Cohen’s d of zero denotes no effect, whereas 0.2, 0.5 and 0.8 
represent small, medium and large effects, respectively 149, 150.  Descriptive data of the two 
groups were compared using independent t-tests. 
 
RESULTS 
 
Participants 
Table 6 shows the participant characteristics of the CP group.  The groups were matched for 
age (22.7 ± 3.6 and 26.1 ± 3.7 years, CP and AB respectively).  Body Mass Index (BMI) 
calculated as kilograms per meters was significantly lower in the CP group (22.1 ± 1.4 and 
24.4 ± 2.1 kg/m2, CP and AB respectively, P < 0.05) but bilateral skinfold measurements 
were similar in both groups.   
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Table 6:  International Paralympic Committee competition classification, level of competition, 
diagnosis, resting Ashworth Scale spasticity level, involved side and current 100m sprint time of six 
participants with cerebral palsy 
 
Participant IPC 
class 
Level of 
competition 
Diagnosis Resting 
spasticity 
Involved 
side 
100m 
time (s) 
1 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 11.54 
2 T 38 Paralympic Hypertonic 
hemiplegia 
1 – 2 Left 11.29 
3 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 12.21 
4 T 37 National Hypertonic 
hemiplegia 
1 – 2 Right 12.49 
5 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 12.6 
6 T 38 Paralympic Athetoid 
hemiplegia 
- Left 11.21 
Mean (SD) -  -  - 11.9 (0.9) 
 
Multistage shuttle run test 
Performance during the adapted MSRT was different between AB and CP (244.1 ± 56.1 vs. 
164.8 ± 17.9 shuttles completed in AB and CP, respectively, P < 0.001).  However, volitional 
exhaustion (fatigue) was marked by similar maximal HR (186 ± 9 bpm in AB vs. 190 ± 8 bpm 
in CP) and RPE (19.8 ± 0.6 units in AB and 18.1 ± 1.9 units in CP). 
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40m Sprint Test 
40m ST was 5.3 ± 0.2 s (PRE) and 5.4 ± 0.2 s (POST) for the AB group and 5.6 ± 0.3 s 
(PRE) and 5.9 ± 0.4 s (POST) for the CP group (Table 7, Figure 7 A).  The AB group was 
faster than the CP group in both the PRE and POST 40m ST (P < 0.01, Group main effect).  
The CP group was significantly slower in the POST 40m ST (P < 0.001, Interaction effect), 
whereas the AB group showed a strong tendency to be slower POST 40m ST (P = 0.054).  
Cohen’s d was 0.76 and 0.60 for CP and AB groups, respectively, representing a medium 
effect PRE to POST fatigue. 
 
Vertical Jump Test 
Vertical Jump (both legs) 
VJ-B jump height was greater in the AB group compared to the CP group (54.5 ± 4.6 cm 
(AB) vs. 44.9 ± 4.5 cm (CP) for PRE and 55.7 ± 4.9 cm (AB) vs. 45.5 ± 4.1 cm (CP) for 
POST, Table 7, Figure 7 B, P < 0.0005, Group main effect).  Neither the AB nor CP group 
jump heights changed significantly after fatigue. 
 
Vertical Jump (affected leg) 
Jump height was higher in the AB group at both PRE and POST MSRT (51.4 ± 2.9 cm 
(PRE) and 54.5 ± 3.6 cm (POST) for AB, vs. 34.3 ± 7.8 cm (PRE) and 34.7 ± 8.6 cm (POST) 
for CP, Table 7, Figure 7 C, P < 0.00000).  Fatigue did not affect jump height on the A leg in 
either group. 
 
Vertical Jump (non-affected leg) 
No significant differences were found in VJ-NA between AB and CP (50.2 ± 4.9 cm (PRE) 
and 53.3 ± 5.7 cm (POST) for AB and 45.9 ± 5.8 cm (PRE) and 46.1 ± 4.9 cm (POST) for 
CP, Table 7, Figure 7 D).  There was no effect of fatigue on jump height during VJ-NA. 
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Table 7:  Performance in seconds in the able-bodied and cerebral palsy groups in 40m Sprint Test 
(40m ST, s) and vertical jump performances in centimetres on both legs (VJ-B, cm), affected leg (VJ-
A, cm) and non-affected leg (VJ-NA) from PRE to POST fatigue.  $ P < 0.001 group main effect, † P < 
0.05 time x group interaction. 
 
 AB CP 
 PRE POST PRE POST 
40m ST (s) 5.3 ± 0.2       $ 5.4 ± 0.2      $ 5.6 ± 0.3 5.9 ± 0.4       † 
VJ-B (cm) 54.5 ± 4.6 55.7 ± 4.9 44.9 ± 4.5      $ 45.5 ± 4.1     $ 
VJ-A (cm) 51.4 ± 2.9 54.5 ± 3.6 34.3 ± 7.8      $ 34.7 ± 8.6     $ 
VJ-NA (cm) 50.2 ± 4.9 53.3 ± 5.7 45.9 ± 5.8 46.1 ± 4.9 
 
 
 
Figure 7:  Time in seconds (s) for 40m sprint test (Figure 7 A), vertical jump height on both legs 
(Figure 7 B), vertical jump height on affected leg (Figure 7 C) and vertical jump height on non-affected 
leg (Figure 7 D) for able-bodied group (AB, black bars) and cerebral palsy group (CP, grey bars) from 
PRE and POST fatigue.  $ P < 0.001 group main effect, † P < 0.05 time x group interaction. 
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Electromyography 
Figures 8 A - E, 9 A - E, 10 A - E and 11 A - E depict normalised EMG amplitude expressed 
as percentage maximum activation (% max) on the A and NA sides of the five measured 
muscles in the AB group (black bars) and the CP group (grey bars). 
 
40m Sprint Test 
EMG of all tested muscles during the 40m ST changed similarly following the MSRT in the 
CP and AB groups.  A significant reduction in EMG activity was observed in four of the five 
muscles after fatigue in both groups (Figure 8 B, GM; Figure 8 C, BF; Figure 8 D, VLO; 
Figure 8 E, GC; Time main effect, P < 0.05) while no difference was found in the ES (Figure 
8 A). 
 
Chapter 4 
 
 
Department of Human Biology, University of Cape Town 78 
 
Figure 8:  40m sprint test EMG: Normalised muscle activation of the 40m sprint for affected/non-
dominant side (A, left panel) and non-affected/dominant side (NA, right panel) for the able-bodied 
group (AB, black bars) and cerebral palsy group (CP, grey bars) from PRE to POST fatigue, for 
erector spinae (Figure 8 A), gluteus medius (Figure 8 B), biceps femoris (Figure 8 C), vastus lateralis  
(Figure 8 D) and gastrocnemius (Figure 8 E). * P < 0.05 time main effect. 
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Vertical Jump (both legs) 
There was a time main effect for GM, VLO and GC, which decreased significantly after 
fatigue in both groups (Figure 9, P < 0.05).  EMG activity was lower on the NA side of both 
the CP and AB groups in three of the five measured muscles (Figure 9 A, ES; Figure 9 B, 
GM; Figure 9 E, GC; Side main effect, P < 0.05). 
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Figure 9:  VJ-B EMG: Normalised muscle activation of the vertical jump on both legs (VJ-B) for 
affected/non-dominant side (A, left panel) and non-affected/dominant side (NA, right panel) for the 
able-bodied group (AB, black bars) and cerebral palsy group (CP, grey bars) from PRE to POST 
fatigue, for erector spinae (Figure 9 A), gluteus medius (Figure 9 B), biceps femoris (Figure 9 C), 
vastus lateralis (Figure 9 D) and gastrocnemius (Figure 9 E). * P < 0.05 time main effect, # P < 0.05 
group main effect. 
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Vertical jump (affected leg) 
In the VJ-A, EMG activity was lower on the NA side in both groups, in four of the five 
measured muscles (Figure 10 A, ES; Figure 10 B, GM; Figure 10 D, VLO; Figure 10E, GC; 
Side main effect, P < 001).  EMG activity decreased after fatigue on both sides in GC and 
VLO in both groups (Figure 10 D, VLO; Figure 10 E, GC; Time main effect, P < 0.05) and 
EMG activity was lower in VLO in the AB group compared to the CP group (Figure 10 D, 
VLO; Group main effect, P < 0.05). 
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Figure 10:  VJ-A EMG: Normalised muscle activation of the vertical jump on the affected leg (VJ-A) 
for affected/non-dominant side (A, left panel) and non-affected/dominant side (NA, right panel) for the 
able-bodied group (AB, black bars) and cerebral palsy group (CP, grey bars) from PRE to POST 
fatigue, for erector spinae (Figure 10 A), gluteus medius (Figure 10 B), biceps femoris (Figure 10 C), 
vastus lateralis (Figure 10 D) and gastrocnemius (Figure 10 E). * P < 0.05 time main effect, # P < 0.05 
sides main effect, $ P < 0.05 time x group interaction. 
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Vertical jump (non-affected leg) 
During VJ-NA, there was no difference between the CP and AB groups.  EMG activity was 
lower in the NA ES than the A ES (Figure 11 A, P < 0.01), and was significantly higher in the 
NA VLO compared to the A VLO (Figure 11 D; Side main effect, P < 0.01).  There was a 
similar reduction in activity with fatigue in two muscles (Figure 11 B, GM; Figure 11 D, VLO; 
Time main effect, P < 0.05). 
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Figure 11:  VJ-NA EMG: Normalised muscle activation of the vertical jump on the non-affected leg 
(VJ-NA) for affected/non-dominant side (A, left panel) and non-affected/dominant side (NA, right 
panel) for the able-bodied group (AB, black bars) and cerebral palsy group (CP, grey bars) from PRE 
to POST fatigue, for erector spinae (Figure 11 A), gluteus medius (Figure 11 B), biceps femoris 
(Figure 11 C), vastus lateralis (Figure 11 D) and gastrocnemius (Figure 11 E). * P < 0.05 time main 
effect, # P < 0.05 sides main effect. 
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DISCUSSION 
 
The present study investigated the effect of fatiguing exercise on subsequent explosive 
sprint running performance and neuromuscular characteristics in elite Paralympic athletes 
with CP.  There were two important findings in the present chapter, namely: 1) the similarity 
in the magnitude of fatigue between athletes with CP and AB athletes, and 2) the jump 
performance and associated neuromuscular asymmetries that were identified in athletes with 
CP.  
 
The first important finding of this study was the magnitude-based similarity in fatigue in both 
groups.  40m ST performance was affected by fatigue from PRE to POST similarly in both 
groups, while VJ performance was not affected by fatiguing exercise in either group.  These 
similarities in response to fatigue between the groups were supported by the finding of 
similar EMG measurements in the trials.  Previous research evaluating fatigue as a decline 
in force output over repeated muscle contractions has suggested that individuals with CP 
display greater fatigue resistance compared to AB individuals 17, 81, 82, 151.  However, the 
apparent ability to resist fatigue in individuals with CP is likely the consequence of an 
inability to generate high workloads (and the resultant physiological and metabolic changes 
that cause fatigue) from the onset of exercise 152.  In individuals with CP, muscle weakness 
exists as a result of numerous central deficits, which impairs the ability to generate higher 
force outputs.  These central deficits include impaired central drive resulting in lower 
voluntary muscle activation, impaired motor unit firing rate modulation with altered firing 
sequencing, which can manifest as spasticity and co-activation 17, 81, 82.  Furthermore, 
peripheral changes as a consequence of central insult include muscular weakness, stiffness 
and increased collagen within the muscle.  Importantly, a predominance of Type I slow-
twitch muscle fibres and atrophy of Type II fast-twitch muscle fibres has been identified in 
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individuals with CP, purportedly as a result of constant low-level muscle activation 
associated with spasticity 17, 18, 76, 81, 82.  However, the studies reporting greater fatigue 
resistance in individuals with CP were conducted in populations of sedentary children with 
CP, where confounding factors of physical inactivity and muscular immaturity may further 
obscure the paretic muscle’s true response to fatiguing exercise. 
 
The present study has shown that sprint and explosive jump performance is similarly 
affected by a fatiguing bout of exercise in a group of elite Paralympic athletes with CP, 
compared to AB athletes.  Thus, the magnitude of fatigue resistance was not different 
between the groups.  In fact, there was statistically more fatigue in the CP group than the AB 
group in the 40m ST, which further denounces the hypothesis that fatigue resistance is 
present in individuals with CP.  This similarity in response to fatigue could be attributed to 
similarities in initial performance between the groups, which whilst significant, were 
considerably smaller than those documented in previous research. 
 
In Chapter 3 of this thesis, the performance deficit observed between CP and AB groups 
was 10%, compared to the 6% and 9% deficits in 40m ST performance PRE- and POST 
fatigue found in the present chapter, respectively.  Furthermore, the present study described 
a deficit of 18% was observed during vertical jumps off both legs and a 33-36% deficit in 
performance in the A leg (Figure 7).  This was considerably smaller than the power and 
strength deficits observed in sedentary individuals with CP 17, 18, 49, 50. 
 
These relative similarities with respect to performance may explain the comparable response 
to a fatiguing bout of exercise between groups.  In both CP and AB groups, 40m ST was 
compromised by fatigue (5% decrease in the CP group (Medium effect, 0.76) and 2% 
decrease in the AB group (Medium effect, 0.60, Figure 7 A).  However, it was found that 
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jump performances (VJ-B, VJ-A, VJ-NA, Figure 7 B-D) were not affected by fatigue in either 
the CP or AB groups.  It is possible the finding of no change from PRE to POST in VJ 
performance in either group resulted from cumulative rest periods, and short term muscle 
recovery, over the testing protocol 153, 154, whilst 40m ST performance reflected a true 
response to the MSRT. 
 
During the 40m ST, all associated normalised EMG measures showed similar changes from 
PRE to POST fatigue in both groups (P<0.05, Figure 8).  This finding further supports the 
findings of Chapter 3 that highly trained individuals with CP fatigue similarly to AB individuals 
measured in this chapter.  Changes in EMG activity were characterized by a reduction in 
muscle activation in four of the five measured muscles.  This supports previous research 
showing that the central drive to recruit motor units is reduced with the onset of fatigue in AB 
individuals, and that this is associated with decreased power output or exercise intensity 
over the course of an exercise trial 117, 155-159.  
 
Furthermore, EMG activity measured during all vertical jumps also changed in a similar 
manner in both groups from PRE to POST fatigue (Figures 9 - 11), with the exception of 
increased normalised VLO activity during VJ-A in the CP group (Figure 10 D).  Other EMG 
measurements reflected the expected reductions in muscle activity after fatigue, including 
reduced EMG activity during the 40m ST POST fatigue (Figure 8) and during VJ in selected 
muscles, despite maintenance of performance from PRE to POST (Figures 9 - 11), but were 
similar between AB and CP groups. 
 
The second important finding was related to the differences observed in the VJ between A 
and NA sides in the athletes with CP.  The study design in this study enabled assessment of 
each leg individually, as well as the combined leg performance (VJ-B).  Significantly reduced 
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jumping performance was observed during VJ-A and VJ-B, but not in VJ-NA, in the CP 
group (0% deficit in VJ-NA, compared to 18% in VJ-B and 33 - 36% in VJ-A, Figure 7 B - D).  
This finding demonstrated that when both legs are used together (VJ-B), performance 
deficits result from the large influence of the A leg’s performance capacity, but that the high 
levels of training undertaken by the CP group, resulted in identical performance measured 
on the NA side of athletes with CP, and D side of the AB athletes.  
 
The asymmetry between A and NA legs is similar to levels of asymmetry observed in 
sedentary individuals with CP 23.  However, previous literature has clearly stated that there is 
an “affected” and “less-affected” side in hemiplegic individuals with CP due to the brain’s 
adaptation to central damage which produces bilateral impairment after unilateral brain injury 
160.  That is, the brain’s adaptation to unilateral upper motor neuron lesions, as well as 
subsequent functional effects of these lesions, result in secondary changes, including 
weakness, on the NA side of individuals with CP.  Indeed, these secondary neuroplastic 
changes have been previously improved in children with CP, using constraint-induced 
movement therapy, a method where the use of the A side is increased by constraining the 
non-affected limb 161, 162. 
 
The current group of athletes with CP had the same absolute performance on their NA leg 
as National and International field hockey athletes, supporting Chapters 2 and 3 of this 
thesis that suggested that long term training may result in an adaptation toward AB 
physiology, rather than toward impairment.  This finding also suggests that the individual 
with CP is highly trainable through high levels of physical activity.  However, this possible 
maximum adaptation toward typically developed levels did not eliminate the asymmetry 
between A and NA limbs, as seen in VJ-A.  Assuming the asymmetry was to remain 
constant in all activities, it may be the primary explanation for deficits seen in the VJ-B 
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(18%), 40m ST (6 – 9%) and indeed, Paralympic track performance (13 – 20% for T38 and 
T37 100 m world record performance compared to AB world record performance), where 
both limbs contribute to performance outcomes. 
 
The finding that athletes perform towards their A leg’s capacity while performing activities 
involving both legs was supported by the finding of significantly lower EMG in the NA leg 
than the A leg, in most muscle groups, for both VJ-B and VJ-A (Figure 9 - 10), but not VJ-NA 
(Figure 11).  This finding suggested that compensation may occur by the central nervous 
system to counteract the underperformance associated with the asymmetry in muscle 
power.  This compensation has previously been explained as the result of injury 163.  
Interestingly, the same compensation strategies were observed in the AB group, indicating 
that all athletes perform at the level of their A (or ND) leg.  However, the asymmetries 
present in AB athletes are not as marked as those in athletes with CP. 
 
The findings in this study support the findings of Chapter 3, as well as provide further insight 
into performance and neuromuscular capacities of Paralympic athletes with CP, but had 
some limitations.  Small sample size, the lack of force measurements during the VJ tests, 
the lack of inclusion of sedentary groups of CP and AB individuals, as well as the lack of 
onsite spasticity testing were limitations in this study.  These factors need to be addressed 
by further research in a larger sample in order to investigate differences between A and NA 
sides, the role of spasticity in performance results of athletes with CP, and the real effect of 
long term athletic training on physiology.  Further research is required in a similar group of 
elite Paralympic athletes with CP to investigate possible explanations for the findings in this 
chapter, and Chapter 3 of the present thesis. 
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CONCLUSION 
 
This chapter described explosive performance, neuromuscular characteristics and fatigue in 
elite Paralympic athletes with CP and AB athletes.  In a sample of elite Paralympic athletes 
with CP in classes T37 and T38 (corresponding to GMFCS Level I), sprint running and 
explosive jumping performance was impaired.  Performance was particularly impaired whilst 
using the A leg, but showed similar levels of fatigue in all tests, compared to the AB group.  It 
was proposed, in accordance with the findings of Chapters 2 and 3, that Paralympic athletes 
with CP may represent a group of individuals who have achieved the highest possible 
adaptation toward normal physiology, as a result of elite level training over many years, 
providing evidence that individuals with CP are highly trainable.  Despite this, a marked 
asymmetry between A and NA legs was found in the present study, indicating that activity 
generated by both legs is performed towards the capacity of the A leg.  Chapter 5 
investigates possible explanations for the findings of the current chapter and the findings of 
Chapter 3. 
 
 
  
  
Department of Human Biology, University of Cape Town 91 
 
 
CHAPTER 5 
CHAPTER 5 - The effect of distance deception on pacing during shuttle running trials 
in Paralympic athletes with cerebral palsy  
The effect of distance deception on pacing during 
shuttle running trials in Paralympic athletes with 
cerebral palsy 
 
 
 
 
The findings of the present chapter have been accepted for publication in the Scandinavian 
Journal of Medicine and Science in Sports (2015) 
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INTRODUCTION 
 
The relationship between exercise performance and fatigue development has been studied 
in humans for many years.  There are various physiological models for fatigue and cessation 
of exercise 164.  The integrated central model of exercise-induced fatigue postulates that 
exercise performance is not limited, but rather regulated by the complex interaction of central 
and peripheral factors that allow the body to perform at near-maximum capacity without 
harmful physiological consequences.  This model proposes that through both efferent motor 
command and afferent feedback, the brain is able to regulate both exercise intensity and the 
perturbations it causes. This is measurable as a pacing strategy, controlled consciously and 
subconsciously, that results in appropriate distribution of resources throughout an exercise 
bout to achieve the desired outcome 165-168.  Cerebral palsy (CP) is a movement disorder 
caused by central insult to various areas of the brain at a young age, which results in altered 
neuromuscular physiology and diminished exercise capacity.   
 
Interestingly, studies examining muscle fatigue (the inability to maintain force output over 
time) in individuals with CP have shown that they exhibit fatigue resistance.  That is, the 
studies showed that individuals with CP display a reduced decline in force output over time 
during repeated maximal isokinetic muscle contractions, but total force output throughout the 
trial was lower than able-bodied (AB) controls 17, 81, 82.  However, the fatigue resistance 
reported in these studies was actually the effect of muscle weakness in the CP group.  
However, in Chapters 3 and 4 of this thesis, using elite Paralympic athletes with CP, it was 
shown that fatigue resistance may not be present in individuals with CP.  Indeed, it was 
demonstrated that athletes with CP fatigue at a similar rate to AB athletes in both 
supramaximal cycling trials (Chapter 3) and running trials following the induction of fatigue 
(Chapter 4).  It was proposed in those chapters that the findings were the result of high 
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intensity training over many years in the elite athlete cohort studied.  Furthermore, it was 
proposed that this training enabled them to produce similar performance characteristics to 
AB controls, including a similar measured decline in power output over time.  Therefore, the 
difference in fatigue resistance between individuals with CP and AB individuals was partly 
eliminated as a result of more similar absolute performance capacities. 
 
The findings of the research raised questions regarding whether there were other factors 
involved in the fatigue resistance observed in CP.  The finding of similar performance 
profiles during cycling exercise in Chapter 3 occurred despite neuromuscular irregularities 
including bilateral co-activation, atypical firing patterns, and continuous irregular muscle 
activation in the 30 second sprint.  The atypical changes observed support anecdotal 
observations of elite athletes with CP falling over the finish line and “tying up” with apparent 
spasticity in the affected limbs at the end of the 100, 200, and 400 meter (m) running events 
in competition.  This raised questions about whether athletes with CP fatigue more readily or 
rather pace themselves differently to AB athletes.  Therefore, the current study aimed to 
investigate whether athletes with CP utilise different pacing strategies during prolonged 
running exercise, compared to AB athletes, in an attempt to understand possible 
explanations underlying the findings of Chapters 3 and 4. 
 
Researchers have used deception trials to challenge pacing strategy utilisation, as it is 
understood that the brain paces exercise according to knowledge of the endpoint of the 
exercise 156, 169.  In this chapter, pacing strategy was examined using shuttle running sets 
totalling 1600 m in two trials (one deceived, DEC; one non-deceived, N-DEC).  It was 
hypothesised that the athletes with CP would adopt a relatively more aggressive pacing 
strategy during the deception trial, when the expectation was for a shorter exercise bout, 
compared to the AB athletes.  This would be observed as a significantly faster performance 
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during the first five sets before deception, and a significant reduction in running speed after 
disclosure of deception. 
 
METHODS 
 
Participants 
Six elite athletes with CP (CP group) and 13 AB athletes (AB group) were recruited for the 
study.  The athletes with CP are all Paralympic track sprinters with hemiplegic CP, including 
athletes who participate in the 100, 200 and 400 m events.  They were all diagnosed by a 
physician, as well as classified as either T37 or T38 athletes, in accordance with criteria 
established by the IPC and the CPISRA classification systems 11, 12, 197.  Athletes classified 
as T37 are classified as having ambulant hemiplegic profiles (as a result of hypertonia, 
athetosis or ataxia) with marked impairment on the affected (A) side and full function on the 
non-affected (NA) side.  T38 athletes are classified as presenting with minimal, yet 
significant, impairment in any limb distribution as a result of hypertonia, athetosis or ataxia.  
Classification of both T37 and T38 athletes includes a score of 1 to 2 on the Modified 
Ashworth Scale, denoting mild to moderate resting spasticity in the affected limbs 12.  All 
athletes with CP fell into Level I or II of the Gross Motor Function Classification System 
(GMFCS) 108, 170. 
 
The AB athletes included in this study were International and National level field hockey 
players.  Only athletes who competed in sprint-specific positions (striker, midfielder) were 
recruited.   
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Each participant in both AB and CP groups provided written informed consent prior to the 
study.  The study was approved by the University’s Human Research Ethics Committee 
(Ref: 156/2011). 
 
General overview of testing 
Participants reported to the laboratory on two occasions, with at least 48 hours between 
visits.  On the first visit, height in meters (m) and body mass in kilograms (kg) were 
measured using calibrated equipment (Seca, Model 708, Germany).  On the two visits, after 
a self-selected warm-up, participants performed a N-DEC trial (1600 m) or a DEC trial (1000 
m + 600 m), in a random order.  Heart rate (HR), ratings of perceived exertion (RPE) and 
bilateral electromyography (EMG) of five muscles was recorded every other shuttle in each 
set.  Specific details of testing methods are described subsequently. 
 
Shuttle Run Test 
Participants were instructed to run 10 shuttles between two lines 20 m apart, which 
constituted one 200 m set.  Each trial consisted of eight such sets, separated by one minute 
rest periods.  Participants were instructed to complete the entire trial in the shortest possible 
time, which required each set to be completed as fast as possible, given the known total 
exercise demand.  Participants were further instructed to touch the 20 m line with their non-
affected/dominant foot.  This was designed to eliminate the effect of turning on performance 
in the groups as much as possible.  In the N-DEC trial, participants were instructed to run 
eight sets of 10 shuttles (1600 m).  In the D trial, participants were informed that they were 
running a shorter distance and were instructed to run five sets of 10 shuttles (1000 m).  
Upon completion of the fifth set however, they were informed that they had been deceived 
and that three additional sets were required (an additional 600 m), thus matching distance in 
both trials to eight sets of 10 shuttles.  The trials were randomised to negate the effect of 
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awareness of deception on subsequent performance, although it must be recognised that 
this can never fully be achieved.  Split times were recorded after every second shuttle, as 
well as for each set, and the entire trial, and expressed in seconds (s). 
 
An additional analysis was performed to determine pacing profiles of the groups in the N-
DEC and DEC trials.  Performance times were averaged for the first five sets, the sixth set, 
and the last three sets, and compared to the mean of the total N-DEC trial, in each athlete.  
Data are given for N-DEC and DEC trials in both AB and CP groups. 
 
Heart rate 
HR was measured continuously throughout all the sets (Polar Electro Oy, Kempele, Finland).  
Measurements were recorded at the completion of each set and expressed as beats per 
minute (bpm). 
 
Ratings of perceived exertion 
RPE was recorded at the completion of every set using the 6 – 20 point Borg Scale 171.  This 
scale represents the participant’s perception of effort required to conduct the exercise and is 
rated from “very very light” to “maximal exertion”.  The scale was explained to all participants 
prior to the start of the trial, using a standardized set of instructions.  Scores were recorded 
at the completion of each set, and reported as absolute score units (6 – 20). 
 
Electromyography 
EMG of five bilateral muscles was measured using a telemetric EMG system (GT2400 G2, 
Noraxon, USA Inc., Arizona, USA).  Muscles tested included erector spinae (ES), gluteus 
medius (GM), biceps femoris (BF), vastus lateratis (VLO) and gastrocnemius medius (GC).  
EMG was measured on both the A and NA sides of both groups, where the A and NA sides 
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in the CP group corresponded with both their own and the AB group’s dominant (D) and non-
dominant (ND) sides, respectively.  Dominance was self-reported.  A specified area over the 
belly of each muscle was shaved and cleaned with ethanol, and two electrodes (Blue 
Sensor, Medicotest, Denmark) were placed 2 centimetres (cm) apart, with the reference 
electrode being placed in the anterior superior iliac spine of the right leg.  Electrode 
placement was in accordance with Surface Electromyography for the Non-Invasive 
Assessment of Muscle (SENIAM) recommendations 115.  To ensure reliable EMG data 
collection, EMG was measured in a rested state as well as during individual manual isolation 
of each muscle.  This ensured that the signals recorded were not artefacts of incorrect 
placement, movement or noise generated by external variables.  For analysis of the EMG 
signal, the raw EMG signals were band passed filtered between 20 and 500 Hz.  All signals 
were rectified and smoothed using root mean square analysis for a 50 millisecond (ms) 
window. 
 
EMG activity was recorded continuously for each set.  A three second epoch of EMG data 
was analysed every alternate shuttle, and averaged for each set.  The EMG was then 
normalised to the highest mean amplitude in an epoch in the shuttles of the first set of either 
DEC and N-DEC trials.  This maximum amplitude represented the self-paced maximum 
muscle activation registered in all trials.  The use of normalising all activity to the first set 
establishes a constant baseline to which all activity is compared, and expressed as a 
percentage maximum activation (% max). 
 
Statistical analyses 
All data were analysed and expressed for the eight sets in the N-DEC and DEC trials in both 
AB and CP groups. Variables included total time (s), HR (bpm) and RPE (scale units) per 
set, and percentage maximum amplitude for A/ND and NA/D sides mean normalised EMG 
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(% max).  All data were analysed using statistical software (Statistica 12; Statsoft Inc, Tulsa, 
OK).  All data was distributed normally and significance was accepted at P<0.05.  
Comparisons were made between AB and CP groups, between N-DEC and DEC trials and 
between A and NA sides, using a four way repeated measures analysis of variance ANOVA 
(group x trial x time x side interaction) for all measured outcomes (shuttle performance, in-
depth pacing analysis, HR, RPE and EMG).  Descriptive data (age and BMI) of the two 
groups were compared using independent t-tests. 
 
RESULTS 
 
Participants 
Table 8 shows the participant characteristics of the CP group.  The groups were matched for 
age (26.1 ± 3.5 vs. 22.7 ± 3.6 years for AB and CP, respectively).  Body mass index (BMI) 
calculated as kilograms per meter was lower in the CP group (24.4 ± 2.1 vs. 22.1 ± 1.4 
kg/m2, AB and CP respectively, P < 0.05). 
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Table 8:  International Paralympic Committee competition classification, level of competition, 
diagnosis, resting Ashworth Scale spasticity level, involved side and current 100m sprint time in 
seconds of six participants with CP 
 
Participant IPC 
class 
Level of 
competition 
Diagnosis Resting 
spasticity 
Involved 
side 
100m 
time (s) 
1 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 11.54 
2 T 38 Paralympic Hypertonic 
hemiplegia 
1 – 2 Left 11.29 
3 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 12.21 
4 T 37 National Hypertonic 
hemiplegia 
1 – 2 Right 12.49 
5 T 37 Paralympic Hypertonic 
hemiplegia 
1 – 2 Right 12.6 
6 T 38 Paralympic Athetoid 
hemiplegia 
- Left 11.21 
Mean (SD) -  -  - 11.9 (0.9) 
 
Performance, heart rate and ratings of perceived exertion 
Table 9 presents raw data of shuttle running performance (s), HR (bpm) and RPE (scale 
units) for eight sets of the N-DEC and DEC trials, of the AB and CP groups.  Statistical 
significance is not shown. 
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Table 9:  Shuttle run performance time (seconds), heart rate (beats per minute) and ratings of perceived exertion (RPE, scale units) for able-body group non-
deceived (AB N-DEC) and deceived (AB DEC) trials and cerebral palsy group non-deceived (CP N-DEC) and deceived (CP DEC) trials.  Statistical 
significance not shown. 
 
  Set 1 Set 2 Set 3 Set 4 Set 5 Set 6 Set 7 Set 8 
Time (s) AB N-DEC 43.2 ± 1.5 45.2 ± 0.8 45.9 ± 1.9 47.4 ± 2.1 48.0 ± 2.7 48.6 ± 3.0 48.3 ± 2.5 47.0 ± 1.9 
 AB DEC 43.1 ± 1.8 44.9 ± 1.3 46.2 ± 1.4 47.1 ± 1.9 47.4 ± 2.8 51.9 ± 3.6 50.8 ± 3.0 48.4 ± 2.2 
 CP N-DEC 48.5 ± 1.4 50.5 ± 1.3 51.8 ± 1.8 51.9 ± 2.3 54.5 ± 1.3 55.4 ± 1.6 55.7 ± 1.1 54.7 ± 2.0 
 CP DEC 47.8 ± 1.2 49.0 ± 1.2 50.6 ± 1.9 51.2 ± 2.1 51.0 ± 1.9 54.7 ± 2.0 55.1 ± 2.6 52.8 ± 2.1 
HR  AB N-DEC 163.3 ± 13.3 167.1 ± 15.0 171.5 ± 13.0 175.3 ± 8.0 177.5 ± 6.1 178.6 ± 6.0 178.9 ± 5.9 181.6 ± 5.9 
(bpm) AB DEC 162.3 ± 11.7 170.7 ± 8.6 173.8 ± 6.4 175.3 ± 6.9 176.4 ± 10.0 173.5 ± 10.6 174.9 ± 9.5 177.8 ± 8.8 
 CP N-DEC 171.4 ± 7.4 178.0 ± 4.4 180.2 ± 6.4 180.4 ± 5.3 180.8 ± 4.3 181.8 ± 5.3 181.6 ± 6.3 185.4 ± 8.0 
 CP DEC 172.3 ± 9.9 181.7 ± 7.2 180.8 ± 2.5 183.7 ± 3.5 187.5 ± 4.7 185.5 ± 2.8 187.5 ± 4.4 190.2 ± 4.6 
RPE  AB N-DEC 12.2 ± 1.4 13.7 ± 1.1 15.1 ± 1.1 16.5 ± 1.2 17.6 ± 1.3 18.4 ± 1.0 18.9 ± 1.0 19.4 ± 0.7 
(units) AB DEC 12.2 ± 1.6 14.1 ± 1.4 16.0 ± 1.5 17.9 ± 0.1 19.1 ± 1.0 19.3 ± 0.8 19. ±  0.7 19.8 ± 0.4 
 CP N-DEC 10.8 ± 2.2 11.8 ± 2.3 13.1 ± 2.3 14.2 ± 2.0 15.2 ± 2.3 16.0 ± 1.8 16.5 ± 2.0 17.7 ± 1.4 
 CP DEC 9.3 ± 1.8 13.2 ± 2.6 14.5 ± 2.8 16.2 ± 2.5 17.8 ± 1.8 18.2 ± 1.6 18.3 ± 1.4 19.0 ± 1.0 
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Shuttle Run Test 
Figure 12 shows total time for eight sets in the AB group N-DEC and DEC trials (Figure 12 
A) and CP group N-DEC and DEC trials (Figure 12 B).  The CP group was significantly 
slower in all eight sets of both trials compared to the AB group (11% difference in N-DEC at 
first set, and 10% difference in DEC at first set, between AB and CP groups, P < 0.001).  
Comparisons were conducted to examine the effect of testing order of DEC and N-DEC on 
performance in the groups, and no difference in order effect was found between the groups. 
 
The global pacing strategy employed was similar between groups, with set time increasing 
progressively over time before a decrease during the eighth set (P < 0.0001).  In DEC trials, 
there was a significant increase in set time at set six after disclosure of deception (P < 
0.001). 
 
 
Figure 12: Performance of AB and CP groups during N-DEC and DEC trials 
Time for eight sets of 10 shuttles, separated by one minute rest periods for able-bodied group non-
deceived (AB N-DEC, solid circle) and deceived (AB DEC, open circle) trials (Figure 12 A); cerebral 
palsy group non-deceived (CP N-DEC, solid triangle) and deceived (CP DEC, open triangle) trials 
(Figure 12 B).  * P < 0.001 time main effect, $ P < 0.001 group main effect, * P < 0.05 trials x group 
interaction, † P < 0.05 trials x time interaction. 
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Figure 13 shows the performance of N-DEC and DEC trials in the AB and CP groups, 
expressed as a percentage change from the N-DEC mean.  This was done to compare the 
effects of deception on the relative pacing strategies utilised when using the N-DEC trials as 
an anchor.  Performance in both groups changed significantly over time (P < 0.001).  All 
trials of both groups were faster in the first five sets, followed by a significantly slower 
running speed for the sixth set and the last three sets compared to the first five sets (P < 
0.05).  The CP DEC trial showed significant differences from the AB DEC trial for all set 
groupings (first five, sixth, and last three).  The CP group began the DEC trial significantly 
faster relative to N-DEC mean compared to the AB group (P < 0.05), then slowed down 
relatively less after deception (sixth set and last three sets, P < 0.05). 
 
 
 
Figure 13: Relative pacing of N-DEC and DEC trials in the AB and CP groups 
Percent change in performance of the first five, sixth, and last three sets (%) for able-bodied group 
non-deceived (AB N-DEC, dark chequered) and deceived (AB DEC, dark brick) trials and cerebral 
palsy group non-deceived (CP N-DEC, solid white) and deceived (CP DEC, white arrows) trials.  * P < 
0.001 time main effect, $ P < 0.01 group main effect, # P < 0.05 trials x group interaction, † P < 0.05 
trials x time interaction. 
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Heart Rate 
Both AB (Figure 14 A) and CP (Figure 14 B) groups’ HR increased significantly over the 
eight sets of shuttle runs in both trials (Figure 14, P < 0.001).  The CP group had a 
significantly higher HR than the AB group throughout the trial (P < 0.05). 
 
 
Figure 14: Heart Rate during N-DEC and DEC trials in the AB and CP groups 
Heart rate for eight sets of 10 shuttles, for able-bodied group non-deceived (AB N-DEC, solid circle) 
and deceived (AB DEC, open circle) trials (Figure 14 A); cerebral palsy group non-deceived (CP N-
DEC, solid triangle) and deceived (CP DEC, open triangle) trials (Figure 14 B).   * P < 0.001 time main 
effect, $ P < 0.05 group main effect. 
 
Ratings of perceived exertion 
Figure 15 displays the RPE for AB (Figure 15 A) and CP (Figure 15 B) groups.  There was a 
significant increase in RPE scores over time in both groups (P < 0.001) as well as a 
significantly lower scores in the CP group compared to the AB group (P < 0.01).  RPE during 
the DEC trial in the CP group was different from all other trials in the first set, with a lower 
RPE value reported than any other trial (P < 0.001). 
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Figure 15: Ratings of perceived exertion during N-DEC and DEC trials in the AB and CP groups 
Ratings of perceived exertion for eight sets of 10 shuttles, for able-bodied group non-deceived (AB N-
DEC, solid circle) and deceived (AB DEC, open circle) trials (Figure 15 A); cerebral palsy group non-
deceived (CP N-DEC, solid triangle) and deceived (CP DEC, open triangle) trials (Figure 15 B).  * P < 
0.001 time main effect, $ P < 0.01 group main effect, † P < 0.001 trials x time x group interaction. 
 
Electromyography 
Figure 16 shows EMG activity for A (left panel) and NA (right panel) muscles in ES (Figure 
16 A), GM (Figure 16 B), BF (Figure 16 C), VLO (Figure 16 D) and GC (Figure 16 E) 
muscles for AB and CP groups for both N-DEC and DEC trials.  Both NA (D) and A (ND) 
sides of four muscles (Figure 16 A, ES; Figure 16 C, BF; Figure 16 D, VLO; Figure 16 E, 
GC) displayed a significant decrease in skeletal muscle activity over time in both N-DEC and 
DEC trials (P < 0.05).  The A ES had significantly lower activity than the NA ES in the CP 
group, as well as ES activity in the AB group in both trials (Figure 16 A; P < 0.01).  Skeletal 
muscle EMG activity was significantly lower in both A and NA sides of the CP DEC trial at 
set eight compared to all other trials in both CP and AB groups (Figure 16 A, ES; Figure 16 
E, GC; P < 0.05).  Skeletal muscle activity of the VLO was significantly higher on the A side 
in the DEC trial, than all other trials or sides (Figure 16 D, VLO; P < 0.01). 
 
Chapter 5 
 
 
Department of Human Biology, University of Cape Town 105 
 
Figure 16: Muscle activity of the A and NA sides in the CP and AB groups during N-DEC and 
DEC trials 
Normalised muscle activity of eight sets of 10 shuttles, for affected/non-dominant side (left panel) and 
non-affected/dominant side (right panel) for the able-bodied group non-deceived (AB N-DEC, solid 
circle) and deceived (AB DEC, open circle) trials and cerebral palsy group non-deceived (CP N-DEC, 
solid triangle) and deceived (CP DEC, open triangle) trials in five bilateral muscles: erector spinae 
(Figure 16 A), gluteus medius (Figure 16 B), biceps femoris (Figure 16 C), vastus lateralis (Figure 16 
D), gastrocnemius medius (Figure 16 E). * P < 0.05 time main effect, † P < 0.05 trials x time x group 
interaction, & P < 0.05 sides x time x group interaction, ^ P < 0.01 trials x sides x group interaction. 
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DISCUSSION 
 
The current study aimed to describe performance and pacing during repeated shuttle 
running in AB athletes and elite Paralympic athletes with CP.  The first finding of the study 
was the difference in performance between the groups.  The AB group ran faster than the 
CP group in both N-DEC (10% faster) and DEC (11% faster) trials (Figure 12), which is 
similar to the 10% difference in supramaximal cycling performance reported in Chapter 3 of 
this thesis.  However, this difference in performance during shuttle running was higher than 
the 6% difference found in maximum sprint performance reported in the same groups of 
athletes in Chapter 4 of this thesis.  This finding demonstrates that the AB athletes were 
running at a higher percentage of maximum than the athletes with CP, and a relative 
underperformance during running in the CP group throughout both D and N-DEC trials. 
 
The difference in performance could be attributed to the effects of CP on performance, or 
perhaps the difference in familiarity with the type of exercise performed in this chapter.  That 
is, the AB group comprised hockey players, for whom a repeated shuttle run consisting of 
approximately 50 seconds at high intensity and one minute recovery is more similar to 
competition than in a group of track sprinters (CP group).  The CP group participated in 
repeated 200 m running drills with one minute recovery during regular training.  Most 
importantly, the primary purpose of this study was to measure fatigue and thus this protocol 
was utilized for its known fatiguing effects. 
 
Analysis of absolute data (Figure 12) did not provide sufficient clarity on pacing between the 
groups, therefore a more detailed analysis of performance over time was performed to 
isolate specific pacing patterns in the groups (Figure 13).  Performance data were analysed 
for both the AB and CP groups for the mean of the first five, sixth and last three sets, relative 
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to their own N-DEC mean, where a negative change indicated relatively faster performance 
in comparison to their N-DEC mean and a positive change indicated poorer performance. 
 
Two important findings revealed in the in-depth pacing analysis (Figure 13) are of particular 
interest.  Firstly, both groups were faster in their first five sets than the mean of the whole N-
DEC trial.  As such, both groups displayed poorer performance in the last three sets of the 
trial (particularly the sixth set).  This observation was expected and has been documented as 
part of a typical pacing strategy during both time-trial performances and in distance deceived 
running trials in AB individuals.  In these studies, it has typically been found that 
performance decreases significantly, immediately following disclosure of deception, before a 
certain level of recovery and an endspurt in performance is observed, which is repeated in 
this study 164-167, 167, 168. 
 
In a deception trial, the central regulator, or brain, is deceived into believing it has a certain 
workload to complete, and regulates the allocation of resources accordingly, as pacing is 
highly dependent on knowledge of the exercise endpoint.  Upon disclosure of deception 
however, the anticipatory calculations must be adjusted for a new endpoint, often with 
minimal reserve remaining.  In the present study, the deception was revealed at the 
completion of the expected exercise bout, which would, according to the previous research 
discussed above, coincide with the depletion of all physiological resources and which would 
render any further exercise impossible until some recovery is achieved.  This was not the 
case in the present chapter, as both AB and CP groups were able to continue exercising for 
a sixth set, albeit at a reduced intensity, and so a reserve was clearly maintained even with 
the known endpoint of exercise approaching.  This reserve during maximal exercise of a 
relatively short duration confirms previous work in AB individuals showing that even sprint 
exercise is regulated with the maintenance of reserve capacity 156 168, 172, 173. 
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The most important novel finding in this study was revealed in the analysis of the relative 
pacing strategies, and lends insight into the pacing strategies employed by the CP group.  
Even though similar global pacing strategy was observed in all trials, the CP group appeared 
to approach the DEC trial differently compared to both the CP N-DEC trial and both the AB 
trials (Figure 13).  In the DEC trial, the CP group ran significantly faster in the first five sets 
compared to their N-DEC mean, whereas the AB group did not show this difference.  It was 
expected that both groups would start the DEC trial significantly faster, since the total bout 
was expected to be shorter.  That this was only true in the CP group shows that they 
performed more aggressively in a trial when the anticipated trial duration was reduced.  
Furthermore, the decline in performance in the CP group following disclosure of deception 
(set six) was significantly smaller than the decline in performance observed in the AB group, 
showing that the CP group was relatively less affected by deception than the AB group, and 
were able to maintain more stable performance over all eight sets of the deception trial 
better than the AB group. 
 
This observation in the CP group was unexpected, and was not typical of the pacing strategy 
usually observed in distance-deception running trials 167, 168, providing evidence for the 
utilisation of a conservative pacing strategy in this group of athletes.  However, it must be 
borne in mind that the changes shown in Figure 13 are expressed relative to the N-DEC 
mean, and so this atypical pacing finding in the CP group would also be possible if the N-
DEC trial was a relative underperformance.  This would be possible if the comparison of the 
sets in the DEC trial were compared to a slower benchmark, artificially exaggerating them 
and creating a false impression of a flatter trajectory even after fatigue. 
 
Identifying the possibility of conservative pacing strategy utilisation is difficult.  The 
observation of similar HR measurements in the DEC and N-DEC trials showed that the CP 
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group performed both trials at the same intensity from the outset.  This was also the case for 
the AB group (Figure 14), showing that the N-DEC trials were maximally performed, if HR is 
used as an indicator of physiological stress. 
 
With respect to RPE, it was observed that both groups reported RPE increased over the 
duration of the N-DEC and DEC trials, but the CP group displayed a greater difference 
between the N-DEC and DEC trials (DEC was non-significantly higher, Fig 15).  This finding 
supports the finding of underperformance of the CP group in the N-DEC trial.  Further, it 
provides evidence that the CP group may not necessarily start DEC more aggressively, 
rather that they completed the N-DEC trial with a conservative pacing strategy than the AB 
group.  The AB group also presented with consistently higher RPE scores in both N-DEC 
and DEC trials than the CP group (P < 0.01), further supporting a relative underperformance 
by the CP group in the N-DEC trial. 
 
Previous research conducted using isokinetic strength testing showed that sedentary 
children with CP produce a flattened fatigue profile over the duration of an exercise trial 17, 81, 
82.  This has typically been interpreted as fatigue resistance, thought it too is potentially 
confounded by the possibility that measuring fatigue relative to a lower “anchor” may be 
misleading.  Indeed, the authors of these studies proposed that these findings were the 
result of muscular weakness that limited the children’s initial force output during the repeated 
knee flexion-extension strength testing protocol.  Both central and peripheral factors were 
proposed as mechanisms for the muscular weakness observed in the studies 17, 81-83, 111, 174, 
175. 
 
However, the study described in Chapter 4 which used externally paced maximal trials, 
showed that adult athletes with CP display similar levels of fatigue to AB athletes.  The 
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athlete sample used in that study was the same group of athletes used in the present 
chapter, and comprised elite Paralympic athletes who were more closely matched in sprint 
performance to elite field hockey players.  It was proposed that the observed similarity in 
fatigue may have been the effect of long term exercise training required by athletes for 
participation at Paralympic level competition, innate athletic ability, as well as the study of 
athletes with minimal CP. 
 
The finding of an altered pacing strategy in the CP group in the present study may provide 
insight into the residual effect of CP, and secondary physiological changes as a result of CP, 
on the body.  It has been well documented that individuals with CP are impaired in the 
regulation of exercise, due to brain damage in certain key areas related to movement, from a 
young age.  These areas are the motor cortex, cerebellum and basal ganglia, which control 
and regulate movement, and have also been identified as key areas of the brain involved 
with implementing movement strategies 176.  Further observed in individuals with CP, 
damage to one of these areas of the brain results in dysfunction of that area in terms of 
movement strategy and planning.  Compensation strategies employed by the brain affected 
by CP have been observed as a subconscious underuse of the affected limb during 
functional activities in individuals with CP 177, 178.  Subsequently, these compensation 
strategies have been identified and improved using constraint-induced movement therapy.  
This therapy involves the casting and binding of the NA limb of hemiplegic patients with CP, 
forcing the increased use and improved function of the A limb during fine motor tasks.  
Indeed, this intervention has prevented neglect of the A limb, and subsequent sole reliance 
on the NA limb in mildly to severely affected children with hemiplegic CP 177-179.  
 
During exercise trials, it has been shown that volitional muscle activation is significantly 
decreased in individuals with CP, despite the availability of abundant motor units.  This 
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provides further evidence that a brain affected by CP does not utilise the full resources 
available.  This supports the finding of conservative pacing strategy utilisation in athletes 
with CP in the present chapter.  It is hypothesised that the findings in the present study are 
characteristic of heightened conservative regulation in the brain affected by CP, as a 
protective mechanism.  This hypothesis is supported by the research described previously 
which highlights the compensation of the brain affected by CP 177, 178. 
 
The EMG findings described in this study (Figure 16) indicate few differences between 
groups or trials, despite overall performance and pacing differences between the groups.  In 
both AB and CP groups, EMG decreased significantly over time in A and NA ES (Figure 16 
A), BF (Figure 16 C), VLO (Figure 16 D) and GC (Figure 16 E) muscles.  These findings 
were expected, as muscle activity has shown to decrease over time in prolonged exercise 
trials in AB individuals 155, 156, 158, 159.  The CP group displayed higher mean activation of the A 
VLO during the DEC trial, indicating a possible increased load on the A leg’s power 
generating muscles, in order to maintain performance during the DEC trial.  This was 
possibly also the result of higher running speeds achieved by the CP group in the DEC trial 
compared to the N-DEC trial. 
 
The findings of this study provide the first novel insight into pacing strategy and exercise 
performance in individuals with CP.  Chapters 3 and 4 showed that athletes with CP do not 
present with the fatigue resistance shown in studies performed on sedentary children with 
CP, when externally-paced fatigue was measured.  The current study has provided a 
plausible explanation for the results found in both Chapters 3 and 4.  The altered pacing 
strategy identified in the CP group as a result of deception provides the first evidence that 
these individuals employ a conservative pacing strategy.  This pacing mechanism may have 
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presented as fatigue resistance in previous research, as both fatigue resistance and 
conservative pacing strategies present as lower power output over a longer period of time. 
 
The findings of this study might have clinical implications for the use of different training and 
pacing strategies by coaches and exercise physiologists in order to maximise exercise 
performance in elite athletes with CP.  Furthermore, evaluation of coaching interventions that 
utilise pacing manipulation are required to identify whether deception during training may 
influence performance during competition. 
 
The findings of the present study need to be verified by further research on pacing and 
maximal performance in sedentary and athletic individuals with CP.  The small sample size 
in the CP group, the use of a 20 m shuttle running test instead of a continuous 400 m track, 
and the use of AB hockey athletes instead of AB track and field athletes are limitations of the 
current study.  Specifically, the use of a 400 m continuous track would allow for a better real-
life comparison of pacing between the groups, but 20 m shuttles were used due to 
availability of equipment, the ability to control for environmental factors (wind, heat) and the 
wish to test both groups of athletes in a relatively unfamiliar task, as repeated 200m bouts on 
a track would be highly familiar to the track and field trained CP group.  The results should 
be viewed as an initial insight into possible mechanisms underlying exercise performance in 
a sample of minimally-affected athletes.  Further research using larger samples is required 
to provide additional evidence for the utilisation of subconscious pacing strategies in 
individuals with CP. 
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CONCLUSION 
 
The present chapter provides evidence for the use of a conservative pacing strategy as an 
underlying factor in exercise performance and fatigue profiles in individuals with CP.  This 
study has identified altered pacing strategies during maximal self-paced shuttle running 
exercise using elite Paralympic athletes with CP (classes T37 and T38).  Chapter 2 showed 
similar bone density and fat mass levels between A and NA sides in the CP group, whilst 
Chapters 3 and 4 identified similar fatigue profiles in athletes with CP and AB athletes.  In 
the individual chapters, it was proposed that athletes with CP represent a group of 
individuals who have achieved maximum adaptation toward AB levels.  The current chapter 
supported this proposal, but in alignment with the previous chapters, proposed that there 
may be a ceiling above which adaptation can no longer occur in the athletes with CP.  This 
chapter proposed that individuals with CP may pace exercise conservatively as a heightened 
conservative regulation response.  The present chapter also indicated that conservative 
pacing strategies may be present in elite, highly functional Paralympic athletes with CP, and 
showed that there is a residual effect of CP on the body that cannot be physically surpassed, 
despite the level of physical training or severity of impairment.  
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SUMMARY OF THE THESIS 
CHAPTER 6 - Summary, interpretation, conclusions and clinical implications 
 
Summary, interpretation, conclusions and clinical 
implications 
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SUMMARY OF STUDIES INCLUDED IN THIS THESIS 
 
The present thesis is the first to describe body composition, performance, fatigue and pacing 
characteristics of elite Paralympic athletes with cerebral palsy (CP).  The findings of the 
thesis are described briefly below.  The strengths of this thesis include the first description of 
bone mineral density, in-depth physiology and maximal exercise performance of elite 
Paralympic athletes with CP.  Furthermore, this thesis was the first to investigate 
neuromuscular characteristics and pacing strategies employed by this group of elite athletes. 
 
Chapter 2 investigated in-depth body composition of six elite Paralympic athletes with CP.  It 
was found that there was no difference in bone mineral density and fat mass between 
affected (A) and non-affected (NA) sides of these athletes.  However, there was significantly 
less fat free soft tissue mass on the A side.  This was the first study to describe in-depth 
body composition of elite athletes with CP, and contradicted previous research which 
showed large deficits in bone mineral density in sedentary children with CP compared to 
able-bodied (AB) controls.  It was proposed that the high levels of athletic training 
undertaken by the current sample of athletes may have resulted in the observations 
documented in this study.  It was deemed important to investigate physical function and 
exercise performance in a similar sample of athletes to lend further understanding to these 
observations.  
 
Consequently, Chapter 3 described performance and neuromuscular characteristics of five 
elite Paralympic athletes with CP.  Thirty second Wingate sprint cycling performance was 
10% lower in five athletes with CP, compared to a group of 16 age and gender matched elite 
field hockey, rugby and soccer AB athletes.  However, fatigue indices and muscle activity 
over the trials were similar between the groups.  These findings were in contrast to those 
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documented in the existing scientific literature conducted in young sedentary populations, 
which stated that children with CP present with fatigue resistance as a result of muscle 
weakness.  The similarity in fatigue as well as the closer matching in performance was 
attributed to long term high level athletic training undertaken by these athletes, which 
allowed them to achieve maximal adaptation toward the physiology of AB athletes.  
However, atypical neuromuscular patterns were documented in the athletes with CP, 
indicating that there was still a marked effect of the condition on the neuromuscular 
physiology of these individuals. 
 
Chapter 4 provided further evidence for similar fatigability between elite Paralympic athletes 
with CP and 13 elite AB field hockey athletes, by evaluating explosive sprinting and jumping 
performance before and after an externally paced adapted multistage shuttle run test to 
exhaustion.  The CP group presented with compromised performance in the sprint test (6%) 
and vertical jumps off the A leg (33%) and off both legs (18%), while vertical jump 
performance off the NA leg was equal to those achieved by the AB control group.  Indeed, 
the groups displayed similar fatigue profiles over the course of the testing protocol, which 
supported the findings in Chapter 3.  However, asymmetry with regard to power production 
and neuromuscular activation between A and NA legs indicated that there may be a ceiling 
toward which athletes with CP can adapt. 
 
Chapter 5 evaluated pacing strategies employed by the athletes with CP compared to the 
AB control group, during a distance deceived shuttle running trial.  The CP group of six 
athletes ran 10% slower in all trials compared to 12 elite AB field hockey athletes, which was 
similar to the self-paced deficit in performance observed in Chapter 3.  With the use of 
distance deception, however, pacing strategies employed by both groups were able to be 
assessed.  The CP group presented with altered pacing strategies in the deceived trial, 
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indicating a conservative pacing strategy.  The findings described in Chapter 5 provide a 
possible explanation for the differences in performance despite the similarity in fatigue 
observed between the athletes with CP and AB athletes in Chapters 3 and 4.  It was 
proposed that individuals with CP may pace exercise conservatively as a result of the 
residual effects of CP on the body. 
 
The findings of Chapters 2 - 5 of the current thesis as well as the findings of previous 
research discussed in Chapter 1 lend insight into: 1) the physiological and functional 
capacity of elite Paralympic athletes with CP, and 2) the effect of elite level exercise training 
on this physiology and function in individuals with CP.  The main implications of the current 
thesis will be discussed subsequently. 
 
INTERPRETATION AND IMPLICATIONS OF THIS THESIS 
 
Social integration and sport in individuals with disabilities, and the growth of the 
Paralympic Movement 
It is widely acknowledged that individuals with a disability have, for the most part, suffered 
prejudice and segregation within society for thousands of years.  There is evidence that 
ancient Greek and Roman societies viewed individuals with disabilities as inferior humans, 
resulting in the hiding of adults and children with disabilities away from society in unknown 
locations 180.  During the Middle Ages, individuals with disabilities were tortured or killed to 
rid them of what was believed to be possession by evil spirits 181.  Furthermore, supporters of 
Social Darwinism in the 19th century believed that individuals with disabilities should not be 
state-supported, and argued that preservation of “the unfit” would impede human evolution, 
deeming even sterilisation appropriate as a form of halting heredity of certain disabilities 182. 
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Social isolation and sporting exclusion of individuals with disabilities continued until the 20th 
century.  Indeed, public attitudes and sports policies regarding sport and disability only saw 
progress from the mid-20th century, when a sports competition was held alongside the 1948 
Olympic Games for individuals with spinal cord injuries 8.  Since then, sport and social 
integration for individuals with disabilities has made significant progress through the 
Paralympic Movement and affiliated movements.  As an indicator of the Movement’s 
success, the Paralympic Games have grown over the years, culminating in the 2012 London 
Paralympic Games, which boasted 4176 athletes from 164 countries competing in many 
sports across many classes of disability 183.  Although the Paralympic Movement continues 
to grow in terms of performance (witnessed by the still growing number of athletes involved 
in the sports, as well as continuous breaking of world records) professionalization of athletes 
with disabilities is becoming more common, allowing for comparable commercial athlete 
status between Olympic and Paralympic athletes (as seen by equal medal winnings and 
endorsement deals).  Thus, individuals with disabilities have, in a relatively short period of 
time, gained elite status in the world of international sports participation. 
 
Similarly, classification of impairment in Paralympic sport has seen significant change since 
the inception of the Paralympic Movement.  Individuals with disabilities were initially 
classified medically, before the commencement of functional and ability-specific testing for 
classification.  Some impairments, such as visual impairment, are still based on medical 
classification, whereas most physical impairments are classified into classes of competition 
either categorically (depending on specific factors affecting function and performance) or 
functionally (depending on functional ability of the individual) 11. 
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Cerebral palsy and the current thesis 
With the growth of the Paralympic Movement and progression of sport participation in 
individuals with disabilities, participation in elite sporting events by individuals with CP has 
also become increasingly prevalent.  Athletes with CP participate in mainstream sporting 
events including athletics, swimming and cycling as well as specific sports including boccia 
and 7-a-side football 9. 
 
With the rapid growth of the movement however, especially in areas that do not require 
technological advancement (such as lower limb running prostheses or sports wheelchairs 
184), the progression of science is sometimes slower than that of the practice.  In particular, 
the majority of research in individuals with CP still focuses on quality of life in sedentary 
children 37, 185, 186, with little research on functional capacities of either adults or athletes with 
CP 25, 114, 187, 188.  The physical inactivity in these earlier studies has to be acknowledged as a 
major contributing factor to the significant deficits reported in these studies, which document 
up to a 70% deficit in whole body functional performance in a variety of exercise physiology 
systems 17, 29, 48, 49, 112. 
 
The studies described in this thesis are the first of their kind to describe in-depth physiology 
and functional performance in elite Paralympic athletes with CP.  The investigation of such a 
group of individuals eliminates the confounding effect of sedentary behaviour on the results 
observed in the studies.  As such, the findings of the present thesis are of particular 
importance in furthering the understanding of the true effects of CP on the body, as well as 
the effects of long term exercise training in individuals with CP. 
 
The findings of the present thesis can be interpreted in many ways.  This thesis, having been 
drawn from anecdotal, clinical and empirical areas, would hold varying levels of importance, 
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and different primary findings, depending on the background of the reader.  Therefore, the 
findings of this thesis could hold different implications for a sports scientist compared to a 
sports physician or a coach.  Some of these areas of interest may include: 1) athlete 
development, 2) brain regulation in CP, 3) high performance sports physiology and 
biomechanics in athletes with disabilities, or 4) muscle activity in individuals with CP.  
However, the recurring hypothesis throughout the thesis which suggests that the findings of 
this thesis occurred as a result of long term exercise training holds significant potential for 
the lives of individuals with CP, more than any one finding in isolation. 
 
Implications of long term exercise training 
The use of elite Paralympic athletes in the current thesis provides a valuable insight into the 
effect of high level, long term exercise training from a young age on the individual with CP.  
The athletes used in the studies described in Chapters 2 - 5 of this thesis were all highly 
physically active in AB sports from a young age, before specialising in track and field 
athletics in their mid-teenage years.  They have been specialised in athletics from between 
four and 12 years, and complete high volumes of training, ranging from six to 20 hours per 
week. 
 
In Chapter 1 of this thesis, the effect of short term exercise interventions in children with CP 
was discussed in detail 19, 51, 65.  The very large changes as the result of these interventions 
indicate that the body with CP is highly adaptable.  In fact, it was reported that children with 
CP had approximately twice the improvement in functional performance compared to adult 
studies, further indicating that adaptation at a young age is easier to achieve 44, 189.  
Conversely, it was found that detraining after an exercise intervention was significantly 
marked after only four weeks of inactivity, compared to the effects of detraining in AB 
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individuals 190, 191.  This finding indicates that although high levels of adaptation are possible, 
the positive effects of exercise are lost after a short while if the exercise is not continued. 
 
Chapters 2 - 5 provide the first evidence that long term exercise training interventions may 
provide more benefit to individuals with CP than previously believed.  The similarity in fat 
mass and bone mineral density between A and NA sides reported in Chapter 2; the 
performance deficits of only 6 – 10% reported in Chapters 3 – 5; and the similarity in fatigue 
profiles between athletes with CP and AB athletes reported in Chapter 3 and 4 represent 
novel findings.  These findings indicate that long term high level exercise training may 
positively influence the physiology of the individual with CP toward maximum level of 
adaptation possible.  That is, through exercise, it may be possible for individuals with CP to 
restrict the secondary effects of physical inactivity and CP on the body. 
 
The acceptance of this hypothesis is arguably the most important finding of this thesis, and 
holds the potential to radically change the lives of individuals with CP.  Clinically, the change 
in attitude in the treatment of children affected by CP should shift from minimal play-based 
functional therapy toward higher levels of exercise training from a young age.  This new 
perspective of exercise training would allow these children the opportunity to achieve the full 
potential of their body.  With further research in this area, including longitudinal research on 
high dose exercise training in children with CP, it is possible that this thesis may have 
provided the first evidence to change standard exercise prescription and treatment of 
children and adolescents within this group of individuals with disabilities. 
 
Implications of residual effects of cerebral palsy 
In writing this thesis, two main themes emerged in each chapter.  Firstly, and as discussed 
above, there seemed to be a significant effect of long term athletic training, which could be 
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assessed by using elite Paralympic athletes.  Secondly, and sometimes requiring in-depth 
investigation, a residual effect of CP was observed in these individuals, which high levels of 
elite athletic training could not surpass.  That is, there appears to be a ceiling of impairment 
towards which an individual can adapt, but no further.  The lower fat free soft tissue mass on 
the A side reported in Chapter 2; the muscle activation irregularities observed in Chapter 3; 
the asymmetrical impairment in performance on the A side reported in Chapter 4; as well as 
the altered pacing strategy utilisation reported in Chapter 5 indicate that the effects of CP on 
the body are present even in highly trained individuals. 
 
These findings represent the “weakest link” in the chain of the elite athlete.  And as such, to 
improve these areas of deficit is to improve the whole body.  In the clearest example of 
residual impairment affecting function, Chapter 4 described the vertical jump performance 
impairment as 33% whilst jumping off the A leg, 18% whilst jumping off both legs, whilst the 
NA leg was observed as displaying no performance deficit compared to vertical jump 
performances of elite AB field hockey athletes. Thus, although there were differences in the 
jumping protocols of both legs and single legs, the effect of the A leg’s impairment on the 
activity generated by both legs was clear.  It is therefore logical to assume that should one 
increase the capacity of the A leg, the capacity of the activity generated by both legs would 
improve. 
 
In musculoskeletal rehabilitation, it is commonly taught that progression of rehabilitation is 
dictated by the progress of the affected/injured limb 14.  For example, weight added onto a 
leg press machine, is added at the A leg’s strength threshold, and increased as the A leg 
improves in strength.  The problem with this approach in individuals with CP is that the A leg 
will be permanently impaired to a certain degree, whilst the NA leg, as shown in this thesis, 
can reach the same performance capacity of elite National and International field hockey 
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players.  To train both legs at the progress of the A leg would therefore impede progress of 
the whole body.   
 
The athletes tested in the current thesis already train A and NA legs individually, thus the 
result of comparable power capacities between their NA leg and AB athletes’ legs was 
possible.  However, the athletes involved in this thesis include elite Paralympic athletes who 
receive evidence-based training interventions by their coach.  Standard rehabilitation 
practise in athletes with CP and more particularly, individuals with CP in the general 
population is to always perform activity using both limbs, as described above.  Should a 
movement away from this training approach occur, significantly more improvement might be 
observed in the A limbs, and subsequently the whole body might improve. 
 
It must be noted that to train both legs individually would ultimately increase the asymmetry 
between A and NA legs as observed in the elite cohort of athletes with CP used in this 
thesis, if they are working at their own maximal capacity.  This needs to be considered and 
factored into rehabilitation programs devised by the clinician, to avoid increasing 
compensatory mechanisms in these individuals. 
 
Another implication of these findings, however, is the acceptance of a residual impairment in 
individuals with CP.  The athletes used in this thesis train both legs individually, at very high 
levels, and yet these asymmetries are maintained.  Empirically, it could be said that the 
impairment witnessed in this group of athletes (such as the atypical muscle activation 
findings observed in Chapter 3 and asymmetries observed in Chapters 2 and 4) represents 
the true effect of CP on their bodies.  Had this group not been elite athletes, it is reasonable 
to suggest that the impairments observed would have been significantly more marked, much 
like the impairments reported in the literature using sedentary adults with CP.  The 
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observation of the actual effect of CP on the body, without confounding factors, is of great 
importance in the understanding of the true impairment associated with CP.   
 
Interestingly, these observations may also have implications for the Paralympic classification 
process, where regular classification (as opposed to confirmed classification status of 
athletes with CP) might be able to identify the true effect of CP on the body, and classify 
athletes accordingly, over many years of elite level athletic training.  The relationship 
between the findings of this thesis and possible implications for classification require further 
research. 
 
Implications of central deficit and conservative pacing in cerebral palsy 
The current thesis provides insight into the relationship between fatigue resistance and 
conservative pacing strategies in individuals with CP.  Previous research in children 
proposed that individuals with CP are fatigue resistant as a result of significant muscle 
strength deficits 17, 81-83.  This fatigue resistance was reported as lower force output in the CP 
group, although the lower force was maintained over a longer period of time during exercise 
trials.  In the present thesis, athletes with CP represent a group of individuals who have 
possibly avoided these strength deficits through athletic training, and thus present with 
similar levels of fatigue to elite AB field hockey athletes (Chapter 3 and 4).  However, in 
Chapter 5, pacing strategies employed by athletes with CP and AB athletes were 
investigated in isolation with the use of distance deception.  It was observed that the athletes 
with CP paced the exercise conservatively compared to AB athletes.  Interestingly, this 
conservative pacing strategy presents as maintenance of lower power output over the trial, 
much like the fatigue resistance reported in the earlier studies.  Therefore, it is tempting to 
speculate that the maintenance of lower power output observed in individuals with CP may 
not be the previously proposed fatigue resistance, but rather the utilisation of a subconscious 
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conservative pacing strategy, as a result of the residual effect of CP on the bodies of these 
individuals. 
 
This hypothesis has practical implications for athletes with CP wishing to improve athletic 
performance.  The use of distance and time deception as a coaching technique improves 
performance by forcing the athlete to push beyond comfortable boundaries with respect to 
exertion and encourages them to work into their physiological reserve 156, 192.  This is an 
important aspect of training, as training intensity, although perceived to be maximal by the 
athlete during training, can never fully recreate the unique conditions and intensity of elite 
sports competition.  In athletes with CP, this reserve may be harder to access than AB 
athletes, requiring higher threshold training in these individuals.  However, access to this 
reserve in athletes with CP may significantly influence their competitive edge, and even 
possibly limit the adverse effects of CP experienced toward the end of a race, which is often 
observed as “tying up” with spasticity in the legs.  Indeed, “tying up” toward the finish line in 
athletes with CP may be the result of a conservative pacing strategy limiting access to the 
reserve capacity in these athletes.  Thus, the use of deception by the coach during training 
may have significant effects on outcome with respect to competition.  This is particularly true 
for events longer than 100 m, as the 100 m event is performed as an all-out maximal event 
(despite subconscious pacing during the event), whereas the 200 m or 400 m events require 
conscious pacing strategies during performance, which can be altered during training of 
these athletes. 
 
Application of electromyography as a tool in the rehabilitation and training of 
individuals with cerebral palsy 
The inclusion of muscle activity (EMG) activity in the present thesis was initially designed to 
measure central output indirectly through volitional muscle activation.  However, the findings 
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of irregularities in specific muscle activation in Chapter 3 provided in-depth insight into the 
dysfunctional muscle activation in these individuals.  The identification of these irregularities 
using EMG has clinical implications for the use of this technique in the identification and 
rehabilitation of clinical neuromuscular presentations of individuals with CP. 
 
EMG biofeedback has gained popularity in recent years as a rehabilitative tool 62, 66, 193.  In 
biofeedback, the patient is able to monitor real time muscle activation during specific 
rehabilitation in order to optimise therapy.  In individuals with neuromuscular impairment, 
including those with CP, biofeedback may provide important information during rehabilitation 
which cannot be gleaned from traditional rehabilitation alone.  Indeed, the irregularities in co-
activation timing of both stabilising erector spinae muscles and power producing vastus 
lateralis and biceps femoris muscles, as well as the irregular atypical motor drive (or 
spasticity) of the biceps femoris muscles observed in three participants with CP (Figure 5-6 
in Chapter 3) provide clear examples of areas requiring attention during clinical management 
of specific athletes. 
 
LIMITATIONS OF THIS THESIS 
 
The use of a small sample size 
An important limitation of the current thesis was the use of a small sample of athletes with 
CP.  The use of a small sample size increases the possibility of a Type 2 statistical error 194, 
as well as limits the extrapolation of findings in each study to the greater population of 
individuals with CP.  However, this thesis required a group of elite Paralympic athletes with 
CP in South Africa, which represents a finite pool from which to draw participants.  This 
thesis recruited every athlete possible in the country that met the requirements for inclusion. 
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The use of T37 and T38 athletes with cerebral palsy 
It must be acknowledged that the use of athletes who fall into classes T37 and T38 of the 
current athletics classification represent athletes who are minimally affected with CP 12, 197.  
The decision to investigate this selection of athletes was twofold: 1) this thesis aimed to 
examine function in highly performing ambulant individuals with CP, and 2) T37 and T38 
sprinting athletes were available for the studies of this thesis through their coach.  It may be 
suggested that athletes who fit the hemiplegic profiles associated with neuromuscular 
conditions like CP (classes T35 and T36) be used in the CP sample.  However, the inclusion 
of T35 or T36 athletes would have created a heterogeneous group of athletes with CP, as 
the impairment observed in these groups is significantly higher than in T37 and T38.  Thus 
the decision to select athletes from T37 and T38 classes was also made on the homogeneity 
of the two classes in levels of impairment.  
 
Additionally, athletes who are classified as T37 and T38 fall into Level I – II in the Gross 
Motor Function Classification System, representing ambulant individuals who are self-reliant 
and able to perform physically demanding tasks as well as activities of daily living 7, 10, 170.  
With this in mind, only studies using individuals classified as Level I or II in the gross motor 
function classification system were used as references in this thesis.  This is discussed in 
detail in Chapter 1 and declared in every chapter of this thesis.  Therefore, although the 
findings of the present thesis may be characteristic of using minimally affected athletes with 
CP, it was controlled for as much as possible by only including research conducted on 
similarly affected individuals, upon which conclusions were made. 
 
Selection of the control group 
The current thesis could have been improved by using an AB control group comprising track 
and field athletes.  As discussed above, the CP group was drawn from a finite number of 
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athletes with CP.  Similarly, the number of AB elite sprinters in South Africa is very small, 
with only National athletes available, who reside in a different province to the group of 
Paralympic athletes described in this thesis.  Furthermore, in an effort to match performance 
as closely as possible between the CP and AB groups, sprint specific athletes in running 
sports were used instead of track and field athletes.  The available AB track and field 
athletes in South Africa were difficult to compare in terms of training volume, performance 
times or level of performance to the current sample of athletes with CP.  Further research is 
required using an AB track and field athletics control group. 
 
Study design limitations 
Equipment specific testing limitations 
Certain limitations of the current thesis were noted with regard to equipment.  In Chapter 3, 
the use of bilateral stroke-by-stoke power output on the cycle ergometer would have 
provided greater understanding of the role of A and NA legs in power production.  Similarly, 
the use of floor imbedded force plates in Chapter 4 would have allowed for further 
investigation into the force production/muscle activation ratio in the vertical jump tests on the 
A and NA legs.  In addition, the use of a 400 m continuous track instead of 20 m running 
field in Chapter 5 would have allowed for a better comparison to real life track running 
performances.  These variables were not investigated due to unavailability of equipment 
required for the testing, but would be important to use in the planning of future studies. 
 
Cerebral palsy specific testing limitations 
The use of surface EMG in this thesis was both an innovation and a limitation.  Surface 
electromyography is an indirect measure of volitional muscle activation, and as such, is 
unable to provide actual central output from the brain 195, 196.  Central output would have 
been beneficial to examine, as individuals with CP are characterised by a decrease in 
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central output, and the direct study of this would have provided important insight into the 
brain’s muscle activation capacity in this group of athletes.  Similarly, volitional muscle 
activation is limited in individuals with CP, resulting in lower maximum muscle activation on 
the A side 17, 76, 86.  Therefore, the use of transcranial magnetic stimulation (maximum central 
activation) or M-wave muscle stimulation (maximum muscle activation) would have provided 
more insight into neuromuscular aspects of CP.  These methods were not used in the 
present thesis as the equipment was not available.  However, in the planning of future 
studies, it is important to note that: 1) M-wave stimulation is an aversive procedure, 
particularly to elite athletes, and 2) both transcranial magnetic stimulation and M-wave 
stimulation require a specific stationary testing protocol. 
 
Another limitation in the current thesis was that we chose not to include muscle biopsies.  
This thesis suggests that one of the possible reasons for near matching in performance and 
similarities in fatigue indices between athletes with CP and AB athletes is the preferred 
utilisation of Type II muscle fibres over Type I muscle fibre recruitment, as a result of athletic 
training.  Muscle biopsies of the A and NA sides in the athletes with CP would be able to 
provide evidence for this hypothesis.  However, due to the aversive nature of the procedure, 
it was not performed on this group of elite athletes. 
 
The lack of on-site testing of spasticity on the A and NA sides in the athletes with CP using 
the modified Ashworth Spasticity Scale is a further limitation in this thesis.  Measurement of 
spasticity would have provided insight into the effect of spasticity on the results of the 
present thesis, especially those of altered pacing after deception in Chapter 5.  Spasticity 
was not measured for two main reasons: 1) a qualified professional experienced enough to 
provide reliable results on the highly variable Ashworth scale was not available for testing, 
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and 2) much like M-wave stimulation, the testing protocols of the studies included did not 
allow for the testing of spasticity testing immediately prior and post exercise testing.  
 
SUGGESTIONS FOR FUTURE RESEARCH 
 
The main areas of future research are related to the limitations discussed in the previous 
section.  For example, studies using testing methods not included in the present thesis 
would constitute the next step in providing further insight into the findings documented in the 
present thesis.  Particularly, given the similarity in fatigue profiles between elite athletes with 
CP and AB athletes in this thesis, M-wave stimulation and muscle biopsies would provide 
further valuable insight into the influence of elite athletic training on muscle development and 
activation in this group of athletes. 
 
The most important area of future research required is the use of longitudinal studies in 
larger athlete numbers and additional control groups.  Furthermore, it is suggested that 
future research include the testing of three additional sample groups, namely sedentary 
adults with CP, sedentary AB individuals and a track and field elite athlete control group.  In 
addition, longitudinal research conducted in young individuals with CP is required.  These 
areas of future research would provide new insights into the effect of elite exercise training 
from a young age on physiology and function in individuals with CP, by controlling for the 
possible confounding effects of mild CP and matching to a control group not involved in track 
and field athletics in the current thesis.  Finally, the investigation of training regimens utilised 
by elite athletes with CP may provide insight into specific high performance exercise training 
in this population, and its effect on physiology, function and injury prevention from a young 
age. 
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CONCLUSION 
 
The present thesis aimed to describe body composition, exercise performance, fatigue and 
pacing of elite Paralympic athletes with CP.  This thesis provides novel findings of: 1) body 
composition and bone mineral density similarities between A and NA sides in athletes with 
CP compared to AB athletes, which contrasts the existing literature which reports a 
significant deficit on the A side of individuals with CP, 2) less deficit in performance in 
athletes with CP compared to age and gender matched AB athletes, than stated in research 
conducted using sedentary children with CP, 3) a similar fatigue response between athletes 
with CP and AB athletes, 4) the adoption of a conservative pacing strategy in athletes with 
CP, as the result of deception and 5) the residual effects of the condition in this group of elite 
athletes with CP. 
 
This thesis provides the first evidence for the considerable effect of long term high load 
exercise training from a young age on physiology and functional performance in a group of 
elite Paralympic athletes with CP.  The novel findings of the present thesis have significant 
implications for professionals working in the areas of clinical management, coaching and 
scientific research in individuals with CP. 
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APPENDIX II 
 
Participant Informed Consent 
 
Performance and fatigue characteristics of athletes with cerebral palsy 
INFORMED CONSENT 
 
I have read and understood the information sheet provided to me by the investigator.  The procedures 
and risks have also been explained verbally to me and I have had the opportunity to ask questions 
about the study.  The exact procedures used in the trial have been thoroughly explained to me.  I 
understand the nature, procedures and purpose of this study.  This study has received Ethics Approval 
from UCT (Ref: 156/2011). 
I understand that I am free to ask questions and withdraw from the study at any time, and without 
reason, at any time during the testing process.  I agree to the information gathered in this study to be 
used for research, in a statistical format only.  None of my personal information may be shared and I 
am aware that I will be receiving a gift voucher for my participation in this study. 
I agree to participate in this research study of the UCT/MRC Research Unit for Exercise Science and 
Sports Medicine. 
 
Name of participant:  …………………………………………………… 
 
Signature: …………………………………………………… 
 
 
Name of investigator:  …………………………………………………… 
 
Signature: …………………………………………………… 
 
 
 
 
Principal investigator:     Chairman of Ethics Committee: 
Phoebe Runciman      Marc Blockman 
+2779 074 0097      +2721 406 6492 
phoebe.runciman@gmail.com 
 
 
